

 



<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
  "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml"
      xmlns:foaf="http://xmlns.com/foaf/0.1/"
      xmlns:dc="http://purl.org/dc/terms/"
      xmlns:doi="http://dx.doi.org/"
      xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
      xmlns:xsd="http://www.w3.org/2001/XMLSchema-datatypes#"
      lang="en" xml:lang="en"
      itemscope itemtype="http://schema.org/Article"
      class="no-js">
<head prefix="og: http://ogp.me/ns#">
  <title>PLOS ONE: Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin Production</title>


<link rel="stylesheet" type="text/css"  href="/css/global-min.css?v=izteQ6tu7kgsJZW_xmrYizvKiHM" />


    <!--[if lte IE 7]>
<link rel="stylesheet" type="text/css"  href="/css/lte_ie7-min.css?v=3bykQUyQmReeuobVyPozcJ9LxRc" />
    <![endif]-->


<link rel="stylesheet" type="text/css"  href="/css/jquery-ui-min.css?v=eXDHTEJM0lIAmDe5k0I0Ad4nxNo" />


<link rel="stylesheet" type="text/css"  href="/css/journal.css?v=T7ZVxJfgk9jNxLAJ2qHz1vZpgYU" />


<link rel="stylesheet" type="text/css" media="print" href="/css/print-min.css?v=T5lb0B3q6EXBsuDluc5V5w+AkRc" />


  <link rel="stylesheet" href="http://f.fontdeck.com/s/css/js/www.plosone.org/24557.css" type="text/css"/>

  <!--chartbeat -->
  <script type="text/javascript">var _sf_startpt = (new Date()).getTime()</script>
  <script>document.documentElement.className += ' js';</script>

  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
  <meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7; IE=EmulateIE9"/>
  <meta name="description" content="PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed scientific studies from all disciplines freely available to the whole world."/>
  <meta name="keywords" content="PLOS, Public Library of Science, Open Access, Open-Access, Science, Medicine, Biology, Research, Peer-review, Inclusive, Interdisciplinary, Ante-disciplinary, Physics, Chemistry, Engineering"/>
  <meta name="almHost" content="http://alm.plos.org/api/v3/articles"/>
  <meta name="searchHost" content="http://api.plos.org/search" />
  <meta name="termsHost" content="http://api.plos.org/terms" />
  <meta name="solrApiKey" content="plos"/>
  <meta name="almAPIKey" content="3pezRBRXdyzYW6ztfwft" />
  <meta name="currentJournal" content="PLoSONE" />
  <meta name="almRequestBatchSize" content="" />

  <meta name="citation_publisher" content="Public Library of Science"/>
  <meta name="citation_doi" content="10.1371/journal.pone.0001765"/>
  <meta name="dc.identifier" content="10.1371/journal.pone.0001765" />

    <meta name="citation_title" content="Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin Production"/>
    <meta itemprop="name" content="Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin Production"/>

      <meta name="citation_author" content="Anita M. Hennige"/>
            <meta name="citation_author_institution" content="Department of Internal Medicine, Division of Endocrinology, Nephrology, Vascular Disease and Clinical Chemistry, University of Tübingen, Tübingen, Germany"/>
      <meta name="citation_author" content="Harald Staiger"/>
            <meta name="citation_author_institution" content="Department of Internal Medicine, Division of Endocrinology, Nephrology, Vascular Disease and Clinical Chemistry, University of Tübingen, Tübingen, Germany"/>
      <meta name="citation_author" content="Corinna Wicke"/>
            <meta name="citation_author_institution" content="Department of General, Visceral and Transplantation Surgery, University of Tübingen, Tübingen, Germany"/>
      <meta name="citation_author" content="Fausto Machicao"/>
            <meta name="citation_author_institution" content="Department of Internal Medicine, Division of Endocrinology, Nephrology, Vascular Disease and Clinical Chemistry, University of Tübingen, Tübingen, Germany"/>
      <meta name="citation_author" content="Andreas Fritsche"/>
            <meta name="citation_author_institution" content="Department of Internal Medicine, Division of Endocrinology, Nephrology, Vascular Disease and Clinical Chemistry, University of Tübingen, Tübingen, Germany"/>
      <meta name="citation_author" content="Hans-Ulrich Häring"/>
            <meta name="citation_author_institution" content="Department of Internal Medicine, Division of Endocrinology, Nephrology, Vascular Disease and Clinical Chemistry, University of Tübingen, Tübingen, Germany"/>
      <meta name="citation_author" content="Norbert Stefan"/>
            <meta name="citation_author_institution" content="Department of Internal Medicine, Division of Endocrinology, Nephrology, Vascular Disease and Clinical Chemistry, University of Tübingen, Tübingen, Germany"/>

    <meta name="citation_date" content="2008/3/12"/>

  <meta name="citation_pdf_url" content="http://dx.plos.org/10.1371/journal.pone.0001765.pdf" />

      <meta name="citation_journal_title" content="PLOS ONE" />
    <meta name="citation_firstpage" content="e1765"/>
    <meta name="citation_issue" content="3"/>
    <meta name="citation_volume" content="3"/>
    <meta name="citation_issn" content="1932-6203"/>

    <meta name="citation_journal_abbrev" content="PLoS ONE" />

      <meta name="citation_reference" content="citation_title=The complete cDNA and amino acid sequence of bovine fetuin. Its homology with alpha 2HS glycoprotein and relation to other members of the cystatin superfamily.; citation_author=KM Dziegielewska; citation_author=WM Brown; citation_author=SJ Casey; citation_author=DL Christie; citation_author=RC Foreman; citation_journal_title=J Biol Chem; citation_volume=265; citation_number=1; citation_pages=4354-4357; citation_date=1990; " />
      <meta name="citation_reference" content="citation_title=Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A.; citation_author=B Denecke; citation_author=S Graber; citation_author=C Schafer; citation_author=A Heiss; citation_author=M Woltje; citation_journal_title=Biochem J; citation_volume=376; citation_number=2; citation_pages=135-145; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity.; citation_author=P Auberger; citation_author=L Falquerho; citation_author=JO Contreres; citation_author=G Pages; citation_author=G Le Cam; citation_journal_title=Cell; citation_volume=58; citation_number=3; citation_pages=631-640; citation_date=1989; " />
      <meta name="citation_reference" content="citation_title=The nucleotide and partial amino acid sequences of rat fetuin. Identity with the natural tyrosine kinase inhibitor of the rat insulin receptor.; citation_author=G Rauth; citation_author=O Poschke; citation_author=E Fink; citation_author=M Eulitz; citation_author=S Tippmer; citation_journal_title=Eur J Biochem; citation_volume=204; citation_number=4; citation_pages=523-529; citation_date=1992; " />
      <meta name="citation_reference" content="citation_title=Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level.; citation_author=PR Srinivas; citation_author=AS Wagner; citation_author=LV Reddy; citation_author=DD Deutsch; citation_author=MA Leon; citation_journal_title=Mol Endocrinol; citation_volume=7; citation_number=5; citation_pages=1445-1455; citation_date=1993; " />
      <meta name="citation_reference" content="citation_title=Bovine fetuin is an inhibitor of insulin receptor tyrosine kinase.; citation_author=ST Mathews; citation_author=PR Srinivas; citation_author=MA Leon; citation_author=G Grunberger; citation_journal_title=Life Sci; citation_volume=61; citation_number=6; citation_pages=1583-1592; citation_date=1997; " />
      <meta name="citation_reference" content="citation_title=Alpha2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor.; citation_author=ST Mathews; citation_author=N Chellam; citation_author=PR Srinivas; citation_author=VJ Cintron; citation_author=MA Leon; citation_journal_title=Mol Cell Endocrinol; citation_volume=164; citation_number=7; citation_pages=87-98; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene.; citation_author=ST Mathews; citation_author=GP Singh; citation_author=M Ranalletta; citation_author=VJ Cintron; citation_author=X Qiang; citation_journal_title=Diabetes; citation_volume=51; citation_number=8; citation_pages=2450-2458; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=A synonymous coding polymorphism in the alpha2-Heremans-schmid glycoprotein gene is associated with type 2 diabetes in French Caucasians.; citation_author=A Siddiq; citation_author=F Lepretre; citation_author=S Hercberg; citation_author=P Froguel; citation_author=F Gibson; citation_journal_title=Diabetes; citation_volume=54; citation_number=9; citation_pages=2477-2481; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=alpha2-Heremans-Schmid glycoprotein gene polymorphisms are associated with adipocyte insulin action.; citation_author=I Dahlman; citation_author=P Eriksson; citation_author=M Kaaman; citation_author=H Jiao; citation_author=CM Lindgren; citation_journal_title=Diabetologia; citation_volume=47; citation_number=10; citation_pages=1974-1979; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Adipose conversion of 3T3-L1 cells in a serum-free culture system depends on epidermal growth factor, insulin-like growth factor I, corticosterone, and cyclic AMP.; citation_author=W Schmidt; citation_author=G Pöll-Jordan; citation_author=G Löffler; citation_journal_title=J Biol Chem.; citation_volume=15;265; citation_number=11; citation_pages=15489-15495; citation_date=1990; " />
      <meta name="citation_reference" content="citation_title=Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.; citation_author=T Kadowaki; citation_author=T Yamauchi; citation_author=N Kubota; citation_author=K Hara; citation_author=K Ueki; citation_journal_title=J Clin Invest; citation_volume=116; citation_number=12; citation_pages=1784-92; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia.; citation_author=C Weyer; citation_author=T Funahashi; citation_author=S Tanaka; citation_author=K Hotta; citation_author=Y Matsuzawa; citation_journal_title=J Clin Endocrinol Metab; citation_volume=86; citation_number=13; citation_pages=1930-1935; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans.; citation_author=N Stefan; citation_author=B Vozarova; citation_author=T Funahashi; citation_author=Y Matsuzawa; citation_author=C Weyer; citation_journal_title=Diabetes; citation_volume=51; citation_number=14; citation_pages=1884-1888; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism.; citation_author=O Tschritter; citation_author=A Fritsche; citation_author=C Thamer; citation_author=M Haap; citation_author=F Shirkavand; citation_journal_title=Diabetes; citation_volume=52; citation_number=15; citation_pages=239-243; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function.; citation_author=F Bacha; citation_author=R Saad; citation_author=N Gungor; citation_author=SA Arslanian; citation_journal_title=Diabetes Care; citation_volume=27; citation_number=16; citation_pages=547-552; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Plasma adiponectin levels and risk of myocardial infarction in men.; citation_author=T Pischon; citation_author=CJ Girman; citation_author=GS Hotamisligil; citation_author=N Rifai; citation_author=FB Hu; citation_journal_title=JAMA; citation_volume=291; citation_number=17; citation_pages=1730-1737; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Plasma adiponectin levels and sonographic phenotypes of subclinical carotid artery atherosclerosis: data from the SAPHIR Study.; citation_author=B Iglseder; citation_author=V Mackevics; citation_author=A Stadlmayer; citation_author=G Tasch; citation_author=G Ladurner; citation_journal_title=Stroke; citation_volume=36; citation_number=18; citation_pages=2577-2582; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Adiponectin and future coronary heart disease events among men with type 2 diabetes.; citation_author=MB Schulze; citation_author=I Shai; citation_author=EB Rimm; citation_author=T Li; citation_author=M Rifai; citation_journal_title=Diabetes; citation_volume=54; citation_number=19; citation_pages=534-539; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers.; citation_author=D Rothenbacher; citation_author=H Brenner; citation_author=W Marz; citation_author=W Koenig; citation_journal_title=Eur Heart J; citation_volume=26; citation_number=20; citation_pages=1640-1646; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24.; citation_author=N Vionnet; citation_author=El-H Hani; citation_author=S Dupont; citation_author=S Gallina; citation_author=S Francke; citation_journal_title=Am J Hum Genet; citation_volume=67; citation_number=21; citation_pages=1470-1480; citation_date=200; " />
      <meta name="citation_reference" content="citation_title=Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome.; citation_author=AH Kissebah; citation_author=GE Sonnenberg; citation_author=J Myklebust; citation_author=M Goldstein; citation_author=K Broman; citation_journal_title=Proc Natl Acad Sci U S A; citation_volume=97; citation_number=22; citation_pages=14478-14483; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Linkage of plasma adiponectin levels to 3q27 explained by association with variation in the APM1 gene.; citation_author=TI Pollin; citation_author=K Tanner; citation_author=JR O'connell; citation_author=SH Ott; citation_author=CM Damcott; citation_journal_title=Diabetes; citation_volume=54; citation_number=23; citation_pages=268-274; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans.; citation_author=N Stefan; citation_author=AM Hennige; citation_author=H Staiger; citation_author=J Machann; citation_author=F Schick; citation_journal_title=Diabetes Care; citation_volume=29; citation_number=24; citation_pages=853-857; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects.; citation_author=K Mori; citation_author=M Emoto; citation_author=H Yokoyama; citation_author=T Araki; citation_author=M Teramura; citation_journal_title=Diabetes Care; citation_volume=29; citation_number=25; citation_pages=468; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study.; citation_author=JH Ix; citation_author=MG Shlipak; citation_author=VM Brandenburg; citation_author=S Ali; citation_author=M Ketteler; citation_journal_title=Circulation; citation_volume=113; citation_number=26; citation_pages=1760-1767; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Adipose tissue-derived factors: impact on health and disease.; citation_author=ME Trujillo; citation_author=PE Scherer; citation_journal_title=Endocr Rev. 2006; citation_volume=27; citation_number=27; citation_pages=762-78; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Evidence for a local renin angiotensin system in primary cultured human preadipocytes.; citation_author=P Schling; citation_author=H Mallow; citation_author=A Trindl; citation_author=G Loffler; citation_journal_title=Int J Obes Relat Metab Disord; citation_volume=23; citation_number=28; citation_pages=336-341; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.; citation_author=DR Matthews; citation_author=JP Hosker; citation_author=AS Rudenski; citation_author=BA Naylor; citation_author=DF Treacher; citation_author=RC Turner; citation_journal_title=Diabetologia; citation_volume=28; citation_number=29; citation_pages=412-419; citation_date=1985; " />
      <meta name="citation_reference" content="citation_title=Adipose tissue as an endocrine organ.; citation_author=EE Kershaw; citation_author=JS Flier; citation_journal_title=J Clin Endocrinol Metab; citation_volume=89; citation_number=30; citation_pages=2548-2556; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30).; citation_author=TS Tsao; citation_author=HE Murrey; citation_author=C Hug; citation_author=DH Lee; citation_author=HF Lodish; citation_journal_title=J Biol Chem; citation_volume=277; citation_number=31; citation_pages=29359-29362; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Fetuin, a new globulin isolated from serum.; citation_author=KO Pedersen; citation_journal_title=Nature; citation_volume=154; citation_number=32; citation_pages=575; citation_date=1944; " />
      <meta name="citation_reference" content="citation_title=Systemic inhibition of spontaneous calcification by the serum protein alpha 2-HS glycoprotein/fetuin.; citation_author=W Jahnen-Dechent; citation_author=C Schafer; citation_author=A Heiss; citation_author=J Grotzinger; citation_journal_title=Z Kardiol; citation_volume=90; citation_number=33; citation_pages=47-56; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification.; citation_author=C Schafer; citation_author=A Heiss; citation_author=A Schwarz; citation_author=R Westenfeld; citation_author=M Ketteler; citation_journal_title=J Clin Invest; citation_volume=112; citation_number=34; citation_pages=357-366; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study.; citation_author=M Ketteler; citation_author=P Bongartz; citation_author=R Westenfeld; citation_author=JE Wildberger; citation_author=AH Mahnken; citation_journal_title=Lancet; citation_volume=361; citation_number=35; citation_pages=827-833; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Association of serum fetuin-A with carotid arterial stiffness.; citation_author=K Mori; citation_author=M Emoto; citation_author=T Araki; citation_author=H Yokoyama; citation_author=M Teramura; citation_journal_title=Clin Endocrinol (Oxf); citation_volume=66; citation_number=36; citation_pages=246-50; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Obesity is associated with macrophage accumulation in adipose tissue.; citation_author=SP Weisberg; citation_author=D McCann; citation_author=M Desai; citation_author=M Rosenbaum; citation_author=RL Leibel; citation_journal_title=J Clin Invest; citation_volume=112; citation_number=37; citation_pages=1796-1808; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.; citation_author=H Xu; citation_author=GT Barnes; citation_author=Q Yang; citation_author=G Tan; citation_author=D Yang; citation_journal_title=J Clin Invest; citation_volume=112; citation_number=38; citation_pages=1821-1830; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Regulation of NCAM by growth factors in serum-free myotube cultures.; citation_author=JM Lyles; citation_author=W Amin; citation_author=E Bock; citation_author=CL Weill; citation_journal_title=J Neurosci Res; citation_volume=34; citation_number=39; citation_pages=273-286; citation_date=1993; " />
      <meta name="citation_reference" content="citation_title=Gene transcription in hepatocytes during the acute phase of a systemic inflammation: from transcription factors to target genes.; citation_author=P Ruminy; citation_author=C Gangneux; citation_author=S Claeyssens; citation_author=M Scotte; citation_author=M Daveau; citation_journal_title=Inflamm Res.; citation_volume=50; citation_number=40; citation_pages=383-390; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome.; citation_author=K Hara; citation_author=M Horikoshi; citation_author=T Yamauchi; citation_author=H Yago; citation_author=O Miyazaki; citation_journal_title=Diabetes Care; citation_volume=29; citation_number=41; citation_pages=1357-1362; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males.; citation_author=FF Fisher; citation_author=ME Trujillo; citation_author=W Hanif; citation_author=AH Barnett; citation_author=PG McTernan; citation_journal_title=Diabetologia; citation_volume=48; citation_number=42; citation_pages=1084-1087; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Adiponectin multimeric complexes and the metabolic syndrome trait cluster.; citation_author=C Lara-Castro; citation_author=N Luo; citation_author=P Wallace; citation_author=RL Klein; citation_author=WT Garvey; citation_journal_title=Diabetes; citation_volume=55; citation_number=43; citation_pages=249-259; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes.; citation_author=M Fasshauer; citation_author=J Klein; citation_author=S Neumann; citation_author=M Eszlinger; citation_author=R Paschke; citation_journal_title=Biochem Biophys Res Commun; citation_volume=290; citation_number=44; citation_pages=1084-1089; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Influences of ionomycin, dibutyryl-cycloAMP and tumour necrosis factor-alpha on intracellular amount and secretion of apM1 in differentiating primary human preadipocytes.; citation_author=A Kappes; citation_author=G Loffler; citation_journal_title=Horm Metab Res; citation_volume=32; citation_number=45; citation_pages=548-554; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans.; citation_author=JM Bruun; citation_author=AS Lihn; citation_author=C Verdich; citation_author=SB Pedersen; citation_author=S Toubro; citation_journal_title=Am J Physiol Endocrinol Metab; citation_volume=285; citation_number=46; citation_pages=E527-E533; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels.; citation_author=AS Lihn; citation_author=B Richelsen; citation_author=SB Pedersen; citation_author=SB Haugaard; citation_author=GS Rathje; citation_journal_title=Am J Physiol Endocrinol Metab; citation_volume=285; citation_number=47; citation_pages=E1072-E1080; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes.; citation_author=M Fasshauer; citation_author=S Kralisch; citation_author=M Klier; citation_author=U Lossner; citation_author=M Bluher; citation_journal_title=Biochem Biophys Res Commun; citation_volume=301; citation_number=48; citation_pages=1045-1050; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator.; citation_author=VR Sopasakis; citation_author=M Sandqvist; citation_author=B Gustafson; citation_author=A Hammarstedt; citation_author=M Schmelz; citation_journal_title=Obes Res; citation_volume=12; citation_number=49; citation_pages=454-460; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Mechanisms of Disease: hepatic steatosis in type 2 diabetes–pathogenesis and clinical relevance.; citation_author=M Roden; citation_journal_title=Nat Clin Pract Endocrinol Metab; citation_volume=2; citation_number=50; citation_pages=335-48; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Differential expression of insulin receptor tyrosine kinase inhibitor (fetuin) gene in a model of diet-induced obesity.; citation_author=X Lin; citation_author=HD Braymer; citation_author=GA Bray; citation_author=DA York; citation_journal_title=Life Sci; citation_volume=63; citation_number=51; citation_pages=145-153; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=Dyslipidemia in visceral obesity: mechanisms, implications, and therapy.; citation_author=DC Chan; citation_author=HP Barrett; citation_author=GF Watts; citation_journal_title=Am J Cardiovasc Drugs; citation_volume=4; citation_number=52; citation_pages=227-246; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Adiponectin: protection of the endothelium.; citation_author=KS Lam; citation_author=A Xu; citation_journal_title=Curr Diab Rep; citation_volume=5; citation_number=53; citation_pages=254-259; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Hepatic steatosis and vascular disease.; citation_author=A Santoliquido; citation_author=C Di Campli; citation_author=L Miele; citation_author=ML Gabrieli; citation_author=A Forgione; citation_journal_title=Eur Rev Med Pharmacol Sci; citation_volume=9; citation_number=54; citation_pages=269-271; citation_date=2005; " />

  <link rel="canonical" href="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001765" />

    <meta name="twitter:card" content="summary"/>
    <meta name="twitter:site" content="@plosone"/>
    <meta name="twitter:title" content="Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin Production"/>
    <meta name="twitter:description" content="BackgroundThe secreted liver protein fetuin-A (AHSG) is up-regulated in hepatic steatosis and the metabolic syndrome. These states are strongly associated with low-grade inflammation and hypoadiponectinemia. We, therefore, hypothesized that fetuin-A may play a role in the regulation of cytokine expression, the modulation of adipose tissue expression and plasma concentration of the insulin-sensitizing and atheroprotective adipokine adiponectin.Methodology and Principal FindingsHuman monocytic THP1 cells and human in vitro differenttiated adipocytes as well as C57BL/6 mice were treated with fetuin-A. mRNA expression of the genes encoding inflammatory cytokines and the adipokine adiponectin (ADIPOQ) was assessed by real-time RT-PCR. In 122 subjects, plasma levels of fetuin-A, adiponectin and, in a subgroup, the multimeric forms of adiponectin were determined. Fetuin-A treatment induced TNF and IL1B mRNA expression in THP1 cells (p&lt;0.05). Treatment of mice with fetuin-A, analogously, resulted in a marked increase in adipose tissue Tnf mRNA as well as Il6 expression (27- and 174-fold, respectively). These effects were accompanied by a decrease in adipose tissue Adipoq mRNA expression and lower circulating adiponectin levels (p&lt;0.05, both). Furthermore, fetuin-A repressed ADIPOQ mRNA expression of human in vitro differentiated adipocytes (p&lt;0.02) and induced inflammatory cytokine expression. In humans in plasma, fetuin-A correlated positively with high-sensitivity C-reactive protein, a marker of subclinical inflammation (r&#8202;=&#8202;0.26, p&#8202;=&#8202;0.01), and negatively with total- (r&#8202;=&#8202;&minus;0.28, p&#8202;=&#8202;0.02) and, particularly, high molecular weight adiponectin (r&#8202;=&#8202;&minus;0.36, p&#8202;=&#8202;0.01).Conclusions and SignificanceWe provide novel evidence that the secreted liver protein fetuin-A induces low-grade inflammation and represses adiponectin production in animals and in humans. These data suggest an important role of fatty liver in the pathophysiology of insulin resistance and atherosclerosis."/>
      <meta name="twitter:image" content="http://dx.plos.org/10.1371/journal.pone.0001765.g004"/>

  <meta property="og:title" content="Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin Production" />
  <meta property="og:type" content="article" />
  <meta property="og:url" content="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001765" />

 <!--end articleInfoX-->

  <link rel="pingback" href="http://www.plosone.org/pingback" />


  <link rel="shortcut icon" href="/images/favicon.ico" type="image/x-icon"/>
  <link rel="home" title="home" href="/"/>
  <link rel="alternate" type="application/rss+xml"
        title="PLOS ONE: New Articles"
        href="http://www.plosone.org/article/feed"/>
</head>
<body>

  <div id="page-wrap">
    <div id="topbanner" class="cf">

<!-- Div for the ad at the top of journal home page-->
<div class="center">
  <div class="title">Advertisement</div>
  <iframe id='a3ac9da4' name='a3ac9da4'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=345&amp;cb=5392'
    frameborder='0' scrolling='no' width='730' height='90'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a3ac9da4&amp;cb=9682'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=345&amp;cb=144&amp;n=a3ac9da4'
      border='0' alt=''/>
    </a>
  </iframe>
</div>    </div>

    <div id="pagehdr-wrap">
      <div id="pagehdr">
        <div id="user" class="nav">
          <ul>
            <li><a href="http://www.plos.org">plos.org</a></li>
            <li><a href="https://register.plos.org/ambra-registration/register.action">create account</a></li>
            <li class="btn-style"><a
              href="/user/secure/secureRedirect.action?goTo=%2Farticle%2FfetchArticle.action%3FarticleURI%3Dinfo%253Adoi%252F10.1371%252Fjournal.pone.0001765">sign in</a>
            </li>
          </ul>
        </div>
        <div class="logo">
          <a href="/"><img src="/images/logo.png" alt="PLOS ONE"></a>
        </div>

<div id="nav-main" class="nav">
  <ul>
        <li id="mn-01"><a href="/taxonomy" class="areas-link">Subject Areas</a></li>
    <li id="mn-02"><a href="javascript:void(0);">For Authors</a>
      <div class="submenu" style="width: 540px; margin-left: -300px;">
        <div class="block">
          <div class="submit-script">
            <h3>Submit your Manuscript</h3>
            <ul>
              <li>Fair, rigorous peer review</li>
              <li>Broad scope and wide reach</li>
            </ul>
            <a href="/static/submissionInstructions" class="btn">get started</a>
          </div>
        </div>
        <div class="menu">
          <ul>
            <li><a href="/static/publish">Why Publish with PLOS ONE</a></li>
            <li><a href="/static/publication">Publication Criteria</a></li>
            <li><a href="/static/editorial">Editorial Policies</a></li>
            <li><a href="/static/guidelines">Preparing A Manuscript</a></li>
            <li><a href="/static/figureGuidelines">Figure and Table Guidelines</a></li>
          <li><a href="/static/supportingInformation">Supporting Information Guidelines</a></li>
            <li><a href="/static/submissionInstructions">Submitting a Manuscript</a></li>
          </ul>
        </div>
      </div>
    </li>

    <li id="mn-03"><a href="javascript:void(0);">About Us</a>
      <div class="submenu" style="width:248px; margin-left:-30px;">
        <div class="menu">
          <ul>
            <li><a href="/static/information">Journal Information</a></li>
            <li><a href="/static/edboard">Editorial Board</a></li>
            <li><a href="/static/reviewerGuidelines">Reviewer Guidelines</a></li>
            <li><a href="/static/almInfo">Article-Level Metrics</a></li>
            <li><a href="/static/license">Open-Access License</a></li>
            <li><a href="/static/downloads">Media Downloads</a></li>
            <li><a href="/static/commentGuidelines">Guidelines for Comments</a></li>
            <li><a href="/static/corrections">Corrections</a></li>
            <li><a href="/static/help">Help Using this Site</a></li>
            <li><a href="/static/contact">Contact Us</a></li>
          </ul>
        </div>
      </div>
    </li>
  </ul>
<div id="db">
  <form name="searchForm" action="/search/simple?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001765" method="get" >
<input type="hidden" name="from" value="globalSimpleSearch" id="from"/><input type="hidden" name="filterJournals" value="PLoSONE" id="filterJournals"/>    <fieldset>
      <legend>Search</legend>
      <label for="search">Search</label>
      <div class="wrap">
        <input id="search" type="text" name="query" placeholder="Search">
        <input type="image" alt="SEARCH" src="/images/icon.search.gif">
      </div>
    </fieldset>
  </form>
    <a id="advSearch" href="/search/advanced?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001765&filterJournals=PLoSONE">advanced search</a>
</div></div>

      </div>
      <!-- pagehdr-->
    </div>
    <!-- pagehdr-wrap -->

  <!--body and html tags gets closed in global_footer.ftl-->
<script type="text/javascript" src="/javascript/mathjax/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>

<div id="pagebdy-wrap">
  <div id="pagebdy">

    <div id="article-block" class="cf">

<div class="article-meta cf">
  <ul id="almSignPost" style="display: none;"></ul>
  <div class="article-type">
    <span class="type oa">Open Access</span>
      <span class="type pr">Peer-Reviewed</span>
  </div>
</div>

<div class="header" id="hdr-article">

<div class="article-kicker">
      <span id="article-type-heading">
        Research Article
      </span>
</div>  <h1 property="dc:title" datatype="" rel="dc:type" href="http://purl.org/dc/dcmitype/Text">
    Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin Production
  </h1>

  <ul class="authors">
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Anita M. Hennige
              <span class="equal-contrib"
                    title="These authors contributed equally to this work">equal contributor</span>, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">

                <p><span class="equal-contrib" title="These authors contributed equally to this work">equal contributor</span>
                Contributed equally to this work with: Anita M. Hennige, Harald Staiger</p>

              
              

                <p>Affiliation:
                  Department of Internal Medicine, Division of Endocrinology, Nephrology, Vascular Disease and Clinical Chemistry, University of Tübingen, Tübingen, Germany
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Harald Staiger
              <span class="equal-contrib"
                    title="These authors contributed equally to this work">equal contributor</span>, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">

                <p><span class="equal-contrib" title="These authors contributed equally to this work">equal contributor</span>
                Contributed equally to this work with: Anita M. Hennige, Harald Staiger</p>

              
              

                <p>Affiliation:
                  Department of Internal Medicine, Division of Endocrinology, Nephrology, Vascular Disease and Clinical Chemistry, University of Tübingen, Tübingen, Germany
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Corinna Wicke, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of General, Visceral and Transplantation Surgery, University of Tübingen, Tübingen, Germany
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Fausto Machicao, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Internal Medicine, Division of Endocrinology, Nephrology, Vascular Disease and Clinical Chemistry, University of Tübingen, Tübingen, Germany
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Andreas Fritsche, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Internal Medicine, Division of Endocrinology, Nephrology, Vascular Disease and Clinical Chemistry, University of Tübingen, Tübingen, Germany
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Hans-Ulrich Häring, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Internal Medicine, Division of Endocrinology, Nephrology, Vascular Disease and Clinical Chemistry, University of Tübingen, Tübingen, Germany
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Norbert Stefan
              <span class="corresponding">mail</span>
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              <p><span class="email">* E-mail:</span> <a href="mailto:norbert.stefan@med.uni-tuebingen.de">norbert.stefan@med.uni-tuebingen.de</a></p>

                <p>Affiliation:
                  Department of Internal Medicine, Division of Endocrinology, Nephrology, Vascular Disease and Clinical Chemistry, University of Tübingen, Tübingen, Germany
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
  </ul>
  <ul class="date-doi-line">
    <li>Published: March 12, 2008</li>
    <li>DOI: 10.1371/journal.pone.0001765</li>
  </ul>


</div><!--end header-->
<div class="main cf" id="pjax-container">
  

<div class="nav items-5" id="nav-article">
  <ul>
  <li>
        <span class="active" name="article">Article</span>
  </li>
  <li>
      <a href="/article/authors/info%3Adoi%2F10.1371%2Fjournal.pone.0001765" name="authors">About the Authors</a>
  </li>
  <li>
      <a href="/article/metrics/info%3Adoi%2F10.1371%2Fjournal.pone.0001765" name="metrics">Metrics</a>
  </li>
  <li>
      <a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0001765" name="comments">Comments</a>
  </li>
  <li>
      <a href="/article/related/info%3Adoi%2F10.1371%2Fjournal.pone.0001765" name="related">Related Content</a>
  </li>
  </ul>
</div>

<script type="text/javascript">
  var selected_tab = "article";
</script>
  <div id="figure-thmbs" class="carousel cf">
    <div class="wrapper">
      <div class="slider">
              <div class="item">
                <a href="#pone-0001765-t001" data-doi="info:doi/10.1371/journal.pone.0001765" data-uri="info:doi/10.1371/journal.pone.0001765.t001" title="Table 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001765.t001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001765-g001" data-doi="info:doi/10.1371/journal.pone.0001765" data-uri="info:doi/10.1371/journal.pone.0001765.g001" title="Figure 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001765.g001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001765-g002" data-doi="info:doi/10.1371/journal.pone.0001765" data-uri="info:doi/10.1371/journal.pone.0001765.g002" title="Figure 2">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001765.g002&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001765-g003" data-doi="info:doi/10.1371/journal.pone.0001765" data-uri="info:doi/10.1371/journal.pone.0001765.g003" title="Figure 3">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001765.g003&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001765-t002" data-doi="info:doi/10.1371/journal.pone.0001765" data-uri="info:doi/10.1371/journal.pone.0001765.t002" title="Table 2">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001765.t002&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001765-t003" data-doi="info:doi/10.1371/journal.pone.0001765" data-uri="info:doi/10.1371/journal.pone.0001765.t003" title="Table 3">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001765.t003&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001765-g004" data-doi="info:doi/10.1371/journal.pone.0001765" data-uri="info:doi/10.1371/journal.pone.0001765.g004" title="Figure 4">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001765.g004&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
      </div>
    </div>
  </div>

  <div class="nav-col">
    <div class="nav" id="nav-article-page">
      <ul>
        <li class="nav-col-comments"><a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0001765">Reader Comments (1)</a></li>
          <li id="nav-figures"><a data-doi="info:doi/10.1371/journal.pone.0001765" >Figures</a></li>
      </ul>
    </div>
  </div>

  <div class="article">







<div class="abstract"><a id="abstract0" name="abstract0" toc="abstract0" title="Abstract"></a><h2>Abstract</h2>
<h3>Background</h3>
<a id="article1.front1.article-meta1.abstract1.sec1.p1" name="article1.front1.article-meta1.abstract1.sec1.p1"></a><p>The secreted liver protein fetuin-A (AHSG) is up-regulated in hepatic steatosis and the metabolic syndrome. These states are strongly associated with low-grade inflammation and hypoadiponectinemia. We, therefore, hypothesized that fetuin-A may play a role in the regulation of cytokine expression, the modulation of adipose tissue expression and plasma concentration of the insulin-sensitizing and atheroprotective adipokine adiponectin.</p>


<h3>Methodology and Principal Findings</h3>
<a id="article1.front1.article-meta1.abstract1.sec2.p1" name="article1.front1.article-meta1.abstract1.sec2.p1"></a><p>Human monocytic THP1 cells and human <em>in vitro</em> differenttiated adipocytes as well as C57BL/6 mice were treated with fetuin-A. mRNA expression of the genes encoding inflammatory cytokines and the adipokine adiponectin (ADIPOQ) was assessed by real-time RT-PCR. In 122 subjects, plasma levels of fetuin-A, adiponectin and, in a subgroup, the multimeric forms of adiponectin were determined. Fetuin-A treatment induced <em>TNF</em> and <em>IL1B</em> mRNA expression in THP1 cells (p&lt;0.05). Treatment of mice with fetuin-A, analogously, resulted in a marked increase in adipose tissue <em>Tnf</em> mRNA as well as <em>Il6</em> expression (27- and 174-fold, respectively). These effects were accompanied by a decrease in adipose tissue <em>Adipoq</em> mRNA expression and lower circulating adiponectin levels (p&lt;0.05, both). Furthermore, fetuin-A repressed <em>ADIPOQ</em> mRNA expression of human <em>in vitro</em> differentiated adipocytes (p&lt;0.02) and induced inflammatory cytokine expression. In humans in plasma, fetuin-A correlated positively with high-sensitivity C-reactive protein, a marker of subclinical inflammation (r = 0.26, p = 0.01), and negatively with total- (r = −0.28, p = 0.02) and, particularly, high molecular weight adiponectin (r = −0.36, p = 0.01).</p>


<h3>Conclusions and Significance</h3>
<a id="article1.front1.article-meta1.abstract1.sec3.p1" name="article1.front1.article-meta1.abstract1.sec3.p1"></a><p>We provide novel evidence that the secreted liver protein fetuin-A induces low-grade inflammation and represses adiponectin production in animals and in humans. These data suggest an important role of fatty liver in the pathophysiology of insulin resistance and atherosclerosis.</p>

</div>


<div class="articleinfo"><p><strong>Citation: </strong>Hennige AM, Staiger H, Wicke C, Machicao F, Fritsche A, et al.  (2008) Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin Production. PLoS ONE 3(3):
          e1765.
            doi:10.1371/journal.pone.0001765</p><p><strong>Academic Editor: </strong>Alessandro Bartolomucci, University of Parma, Italy</p><p><strong>Received:</strong> April 4, 2007; <strong>Accepted:</strong> February 6, 2008; <strong>Published:</strong> March 12, 2008</p><p><strong>Copyright:</strong> © 2008 Hennige et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p><p><strong>Funding: </strong>The study was partially supported grants from the Deutsche Forschungsgemeinschaft(KFO 114 and HE 3653/3-1) and the European Community's frame program FP6 EUGENE2 (LSHM-CT-2004-512013). The funders had a limited influence on the design of the study but no influence on the conduct of the study, on the collection, analysis, and interpretation of the data, and on the preparation, review, or approval of the manuscript.</p><p><strong>Competing interests:</strong> The authors have declared that no competing interests exist.</p></div>





<div id="section1" class="section"><a id="s1" name="s1" toc="s1" title="Introduction"></a><h3>Introduction</h3><a id="article1.body1.sec1.p1" name="article1.body1.sec1.p1"></a><p>Fetuin-A (former name for the human protein: α<sub>2</sub>-Heremans-Schmid glycoprotein, AHSG) is an abundant serum protein <a href="#pone.0001765-Dziegielewska1">[1]</a> that is exclusively produced by the liver, tongue, and placenta <a href="#pone.0001765-Denecke1">[2]</a>. In several studies, fetuin-A was shown to act as a natural inhibitor of the insulin receptor tyrosine kinase in liver and skeletal muscle <a href="#pone.0001765-Auberger1">[3]</a>–<a href="#pone.0001765-Mathews2">[7]</a>. In addition, mice deficient for the gene encoding fetuin-A displayed improved insulin sensitivity and were resistant to weight gain upon a high-fat diet <a href="#pone.0001765-Mathews3">[8]</a>. Besides these well-documented effects of fetuin-A on the insulin receptor of muscle and liver, another mechanism of this protein may include effects on adipose tissue to induce whole-body insulin resistance. Recently, polymorphisms in the gene encoding human fetuin-A were found to be not only associated with type 2 diabetes <a href="#pone.0001765-Siddiq1">[9]</a>, but also to affect insulin action in adipocytes <a href="#pone.0001765-Dahlman1">[10]</a>. Furthermore, fetuin-A was shown to exert direct pro-adipogenic properties <a href="#pone.0001765-Schmidt1">[11]</a>, however, the underlying mechanisms are unknown.</p>
<a id="article1.body1.sec1.p2" name="article1.body1.sec1.p2"></a><p>The genes encoding human fetuin-A (<em>AHSG</em>) and human adiponectin (<em>ADIPOQ</em>), which is almost exclusively secreted from adipose tissue and represents an important determinant of whole-body insulin sensitivity <a href="#pone.0001765-Kadowaki1">[12]</a>–<a href="#pone.0001765-Bacha1">[16]</a> and cardiovascular disease <a href="#pone.0001765-Pischon1">[17]</a>–<a href="#pone.0001765-Rothenbacher1">[20]</a>, are located next to each other on chromosome 3q27. This chromosomal region was previously mapped as a type 2 diabetes and metabolic syndrome susceptibility locus <a href="#pone.0001765-Vionnet1">[21]</a>, <a href="#pone.0001765-Kissebah1">[22]</a>, and also shows close linkage to variation in plasma adiponectin levels <a href="#pone.0001765-Pollin1">[23]</a>. However, not all of the variability in plasma adiponectin levels can be explained by genetic variation of the <em>ADIPOQ</em> gene <a href="#pone.0001765-Pollin1">[23]</a>. Therefore, other genes under this linkage peak may encode proteins regulating adiponectin production with <em>AHSG</em> representing a major candidate.</p>
<a id="article1.body1.sec1.p3" name="article1.body1.sec1.p3"></a><p>Recently, we and others have shown that human plasma fetuin-A levels are correlated with fatty liver, impaired glucose tolerance, and insulin resistance <a href="#pone.0001765-Stefan2">[24]</a>, <a href="#pone.0001765-Mori1">[25]</a>. Moreover, a recent study provided evidence that human plasma fetuin-A levels are strongly associated with the metabolic syndrome and an atherogenic lipid profile <a href="#pone.0001765-Ix1">[26]</a>. Since these states are characterized by subclinical inflammation and hypoadiponectinemia <a href="#pone.0001765-Trujillo1">[27]</a>, and based on the chromosomal localization of <em>AHSG</em>, we investigated whether fetuin-A regulates cytokine expression, modulates adipose tissue expression and the plasma concentration of the insulin-sensitizing and atheroprotective adipokine adiponectin.</p>
</div>

<div id="section2" class="section"><a id="s2" name="s2" toc="s2" title="Material and Methods"></a><h3>Material and Methods</h3>
<h4>Cell culture</h4>
<a id="article1.body1.sec2.sec1.p1" name="article1.body1.sec2.sec1.p1"></a><p>Human THP1 monocytes were obtained from American Type Culture Collection (Manassas, VA, USA) and cultured in IMDM supplemented with 10% (v/v) FCS, 100 IU/ml penicillin, 0.1 mg/ml streptomycin, and 2 mmol/l glutamine. Cells were left untreated or stimulated for 8 and 24 h with 600 µg/ml human fetuin-A (purity ≥95%, Sigma-Aldrich, Steinheim, Germany), a high physiological dose, or human serum albumin for control (ZLB Behring, Marburg, Germany), respectively.</p>
<a id="article1.body1.sec2.sec1.p2" name="article1.body1.sec2.sec1.p2"></a><p>Human preadipocytes were isolated from abdominal subcutaneous fat biopsies as previously described <a href="#pone.0001765-Schling1">[28]</a>. The donors underwent abdominal surgery for clinical purposes and gave informed written consent to the study. Isolated preadipocytes were expanded in α-MEM/Ham's nutrient mixture F12 (1:1) containing 20% (v/v) FCS, 1% (v/v) chicken embryo extract (Sera Laboratories International, Horsted Keynes, UK), 100 IU/ml penicillin, 0.1 mg/ml streptomycin, 0.5 µg/ml fungizone, and 2 mmol/l glutamine. First-pass cells were used for the experiments. At confluence, adipose conversion was induced by shifting the cells into DMEM/Ham's nutrient mixture F12 (1:1), 5% (v/v) FCS, 17 µmol/l pantothenate, 1 µmol/l biotin, 2 µg/ml apo-transferrin, 1 µmol/l insulin, 100 IU/ml penicillin, 0.1 mg/ml streptomycin, 0.5 µg/ml fungizone, and 2 mmol/l glutamine (differentiation medium) supplemented with 0.5 mmol/l 3-isobutyl-1-methyl-xanthine, 1 µmol/l cortisol, 10 µmol/l troglitazone, and 50 µmol/l indomethacin for 7 days. Finally, the cells were allowed to terminally differentiate for another 7 days in differentiation medium without supplements. Medium was changed three times a week. In vitro differentiated adipocytes were washed once with PBS and pretreated overnight with insulin- and FCS-free differentiation medium. Thereafter, cells were incubated for 24 h with or without 300 µg/ml human or bovine fetuin-A, respectively, in insulin- and FCS-free differentiation medium prior to RNA isolation. The procedures were approved by the Ethical Committee of the Tübingen University Medical Department.</p>


<h4>Animal studies</h4>
<a id="article1.body1.sec2.sec2.p1" name="article1.body1.sec2.sec2.p1"></a><p>Male C57BL/6 mice were obtained from Charles River Laboratories (Sulzfeld, Germany). For in vivo stimulation, 12-week-old C57BL/6 mice kept on a regular diet obtained an intraperitoneal bolus of bovine fetuin-A (fetuin-I, Pedersen's preparation, purity ~75%, 0.75 mg/g body weight, ICN, Eschwege, Germany), human fetuin-A (0.5 mg/g body weight), or human serum albumin (0.5 mg/g body weight), respectively. Controls received a comparable amount of diluent (n ≥ 3 each). Serum and perigonadal adipose tissue were removed after 8 h. Tissue samples were stored at 4°C in RNAlater (Ambion, Huntingdon, United Kingdom). All procedures were conducted according to the guidelines of laboratory animal care and were approved by the local governmental commission for animal research. Insulin resistance was estimated by the homeostasis model assessment of insulin resistance (HOMA-IR) and calculated as insulin (µU/ml) · glucose (mM)/22.5 <a href="#pone.0001765-Matthews1">[29]</a>.</p>


<h4>Real-time RT-PCR</h4>
<a id="article1.body1.sec2.sec3.p1" name="article1.body1.sec2.sec3.p1"></a><p>For quantification of mRNA expression in mouse adipose tissue, RNA was isolated with peqGOLD TriFast according to the manufacturer's instructions (Peqlab, Erlangen, Germany). For quantification of THP1 monocyte and human adipocyte mRNA, cells were washed, harvested, and RNA was isolated with RNeasy silica-gel columns according to the manufacturer's instructions (Qiagen, Hilden, Germany). The total RNA was treated with RNase-free DNase I and transcribed into cDNA using AMV reverse transcriptase and the first strand cDNA kit from Roche Diagnostics (Mannheim, Germany). Quantitative PCR was performed with SYBR Green I dye on a high speed thermal cycler with integrated microvolume fluorometer according to the instructions of the manufacturer (Roche Diagnostics, Mannheim, Germany). Primers were obtained from Invitrogen (Karlsruhe, Germany) and PCR conditions are given in <a href="#pone-0001765-t001">Table 1</a>. Measurements were performed in triplicate. Cellular mRNA contents are given, after correction for 28S-rRNA, in relative arbitrary units (RAU or % of control).</p>
<div class="figure" id="pone-0001765-t001"><div class="img"><a name="pone-0001765-t001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001765.t001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001765" data-uri="info:doi/10.1371/journal.pone.0001765.t001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001765.t001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001765.t001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001765.t001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001765.t001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001765.t001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001765.t001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001765.t001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001765.t001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001765.t001.TIF"></span>)
                </a></li></ul></div><p><strong>Table 1.  <span>Conditions for RT-PCR quantification of specific mRNAs and 28S-rRNA.</span></strong></p><span>doi:10.1371/journal.pone.0001765.t001</span></div>

<h4>Human subjects</h4>
<a id="article1.body1.sec2.sec4.p1" name="article1.body1.sec2.sec4.p1"></a><p>A total of 122 individuals were studied. These subjects were at increased risk for type 2 diabetes and participated in an ongoing study <a href="#pone.0001765-Stefan2">[24]</a>. Individuals were recruited from the southern part of Germany and were not related to each other. The participants did not take any medication known to affect glucose tolerance or insulin sensitivity. Informed written consent was obtained from all participants, and the Ethical Committee of the Tübingen University Medical Department had approved the protocol.</p>


<h4>Hyperinsulinemic euglycemic clamp</h4>
<a id="article1.body1.sec2.sec5.p1" name="article1.body1.sec2.sec5.p1"></a><p>Insulin sensitivity was determined in 49 human subjects as previously described <a href="#pone.0001765-Stefan2">[24]</a>. In brief, subjects received a primed insulin infusion at a rate of 40 mU·m<sup>−2</sup>·min<sup>−1</sup> for 2 h. Plasma was drawn every 5 min for determination of plasma glucose, and glucose infusion was adjusted appropriately to maintain the fasting glucose level. An insulin sensitivity index for systemic glucose uptake (ISI; in µmol kg<sup>−1</sup> min<sup>−1</sup> pM<sup>−1</sup>) was calculated as the mean infusion rate of glucose (in mol kg<sup>−1</sup> min<sup>−1</sup>) necessary to maintain euglycemia during the last 40 min of the hyperinsulinemic euglycemic clamp divided by the steady state plasma insulin concentration. The latter was the mean insulin concentration at min 100, 110, and 120 of the clamp (522±19 pM).</p>


<h4>Other analytical procedures</h4>
<a id="article1.body1.sec2.sec6.p1" name="article1.body1.sec2.sec6.p1"></a><p>Plasma glucose was determined using a bedside glucose analyzer (glucose oxidase method; Yellow Springs Instruments, Yellow Springs, CO, USA). Plasma insulin was determined by an enzyme immunoassay (Abbott Laboratories, Tokyo, Japan). Serum adiponectin levels in mice and fasting plasma fetuin-A levels in human subjects were measured using commercial enzyme-linked immunosorbent assays (ELISA, BioVendor Laboratory Medicine, Brno, Czech Republic). ELISAs were also used to measure serum concentrations of TNF-α, IL-6, and high sensitivity C-reactive protein (hsCRP, R&amp;D Systems Inc., MN, USA). Fasting plasma adiponectin levels in humans were determined by radioimmunoassay (LINCO Research, St. Charles, MO, USA). Multimeric forms of adiponectin were quantified using an enzyme immunoassay (ALPCO Diagnostics, Salem, NH, USA). Percentage of body fat was assessed by bioelectrical impedance.</p>


<h4>Statistical analyses</h4>
<a id="article1.body1.sec2.sec7.p1" name="article1.body1.sec2.sec7.p1"></a><p>Data are given as means±SEM. For 3-group comparisons, data were analyzed by ANOVA followed by Dunnett's test. Statistical comparison between treatment and control group were performed with the Student's t-test. To adjust for the effects of relevant covariates (age, gender, body fat) in the in vivo data, multivariate linear regression analysis was performed using log-transformed data. A p-value &lt;0.05 was considered statistically significant. The statistical software package JMP 4.0 (SAS Institute Inc, Cary, NC, USA) was used.</p>

</div>

<div id="section3" class="section"><a id="s3" name="s3" toc="s3" title="Results"></a><h3>Results</h3>
<h4>Effect of fetuin-A on cytokine mRNA expression of human THP1 monocytes</h4>
<a id="article1.body1.sec3.sec1.p1" name="article1.body1.sec3.sec1.p1"></a><p>Human THP1 monocytes were treated with human fetuin-A and, to evaluate the specificity of fetuin-A's effect and as control for general trophic effects, additionally with human albumin (600 µg/ml, each) for 8 h. Human fetuin-A induced the mRNA expression of <em>TNF</em> (ANOVA, F(14,12) = 9.07, p = 0.004, <a href="#pone-0001765-g001">Figure 1A</a>) and <em>IL1B</em> (ANOVA, F(14,12) = 4.27, p = 0.075, <a href="#pone-0001765-g001">Figure 1B</a>), but did not modulate mRNA expression of <em>PBEF1</em> (encoding visfatin, <a href="#pone-0001765-g001">Figure 1C</a>) or <em>RETN</em> (encoding resistin, <a href="#pone-0001765-g001">Figure 1D</a>). Human albumin as a control did not significantly alter the expression of all these genes (<a href="#pone-0001765-g001">Figure 1A–D</a>). The <em>IL6</em> mRNA expression in these cells was below the detection limit.</p>
<div class="figure" id="pone-0001765-g001"><div class="img"><a name="pone-0001765-g001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001765.g001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001765" data-uri="info:doi/10.1371/journal.pone.0001765.g001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001765.g001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001765.g001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001765.g001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001765.g001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001765.g001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001765.g001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001765.g001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001765.g001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001765.g001.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 1.  <span>mRNA expression in human THP1 monocytes following fetuin-A treatment.</span></strong></p><a id="article1.body1.sec3.sec1.fig1.caption1.p1" name="article1.body1.sec3.sec1.fig1.caption1.p1"></a><p>Expression of <em>TNF</em> (A), <em>IL1B</em> (B), <em>PBEF1</em> (C), and <em>RETN</em> (D) mRNA in human THP1 monocytes before (control) and after treatment with human albumin or human fetuin-A for 8 h. Cellular mRNA contents were corrected for 28S-rRNA (RAU = relative arbitrary units). Data are given as means±SEM (n = 5). Data were analyzed by ANOVA, followed by Dunnett's test.</p>
<span>doi:10.1371/journal.pone.0001765.g001</span></div>

<h4>Effect of fetuin-A on adipose tissue Adipoq mRNA expression and circulating adiponectin in mice</h4>
<a id="article1.body1.sec3.sec2.p1" name="article1.body1.sec3.sec2.p1"></a><p>Within 8 h, intraperitoneal bolus administration of human fetuin-A (0.5 mg/g body weight) into male C57BL/6 mice resulted in insulin resistance (fetuin-A-treated: 22.46±1.27 vs control: 10.21±1.65, T(4) = 9.06, p = 0.004) as estimated by the HOMA-IR. Furthermore, fetuin-A induced adipose tissue mRNA expression of the inflammatory genes <em>Il6</em> and <em>Tnf</em> 174- and 27-fold (ANOVA, F(9,7) = 7.12, p = 0.02, and F(9,7) = 12.38, p = 0.005, respectively, <a href="#pone-0001765-g002">Figure 2A,B</a>). This was accompanied by a 58% decrease in adipose tissue <em>Adipoq</em> mRNA content as compared to control (ANOVA, F(9,7) = 6.15, p = 0.038, <a href="#pone-0001765-g002">Figure 2C</a>), that showed a strong trend after correction for multiple comparison (p = 0.06). To validate these findings on <em>Adipoq</em> mRNA expression, we repeated the experiment and additionally measured serum adiponectin. In the second experiment, treatment of mice with a commercially available bovine fetuin-A (0.75 mg/g body weight) provoked a significant 45% decrease in perigonadal adipose tissue <em>Adipoq</em> mRNA content as compared to baseline (T(4) = 4.30, p = 0.006), whereas no effect was seen in diluent-treated control animals (p = 0.48). Concomitantly, serum adiponectin levels significantly decreased in fetuin-A-treated (T(4) = 2.58, p = 0.031), but not in diluent-treated mice (p = 0.41). To assess specificity for adiponectin, we additionally quantified adipose tissue mRNA expression of other adipokine genes such as <em>Lep</em> (encoding leptin) and <em>Rbp4</em> (encoding retinol-binding protein 4). Fetuin-A did not modulate <em>Lep</em> (<a href="#pone-0001765-g002">Figure 2D</a>) or <em>Rbp4</em> (data not shown) mRNA expression. Treatment of mice with human albumin (0.5 mg/g body weight) did not significantly alter the expression of all these genes (all p&gt;0.2, <a href="#pone-0001765-g002">Figure 2A–D</a>).</p>
<div class="figure" id="pone-0001765-g002"><div class="img"><a name="pone-0001765-g002" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001765.g002&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001765" data-uri="info:doi/10.1371/journal.pone.0001765.g002"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001765.g002&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001765.g002/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001765.g002/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001765.g002/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001765.g002/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001765.g002.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001765.g002/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001765.g002/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001765.g002.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 2.  <span>Cytokine and adipokine mRNA expression in adipose tissue of mice.</span></strong></p><a id="article1.body1.sec3.sec2.fig1.caption1.p1" name="article1.body1.sec3.sec2.fig1.caption1.p1"></a><p>Adipose tissue expression of <em>Il6</em> (A), <em>Tnf</em> (B), <em>Adipoq</em> (C), and <em>Lep</em> (D) mRNA in mice after bolus treatment with human fetuin-A (0.5 mg/g body weight), human albumin (0.5 mg/g body weight), or diluent (control) for 8 h. Cellular mRNA contents were corrected for 28S-rRNA (RAU = relative arbitrary units). Data are given as means±SEM. Data were analyzed by ANOVA, followed by Dunnett's test.</p>
<span>doi:10.1371/journal.pone.0001765.g002</span></div>

<h4>Effect of fetuin-A on ADIPOQ and cytokine mRNA expression of human in vitro differentiated adipocytes</h4>
<a id="article1.body1.sec3.sec3.p1" name="article1.body1.sec3.sec3.p1"></a><p>To test whether suppression of <em>Adipoq</em> mRNA expression by fetuin-A is a direct effect on adipocytes and is not restricted to rodents, we treated <em>in vitro</em> differentiated human adipocytes from four donors with bovine or human fetuin-A (300 µg/ml) for 24 h. These procedures resulted in 30- and 50-% reductions of <em>ADIPOQ</em> mRNA expression, respectively (T(3) = −3.87, p = 0.001 and T(3) = −3.54, p = 0.016, respectively, <a href="#pone-0001765-g003">Figure 3</a>). In analogy to our results in human THP1 monocytes, fetuin-A induced inflammatory markers in adipocytes as well (<em>TNF</em>: p = 0.007; <em>IL6</em>: p = 0.035; <em>CCL2</em>: p = 0.03; <em>IL1B</em>: p = 0.068, data not shown). To further investigate whether paracrine or autocrine effects of fetuin-A exist, we determined the fetuin-A mRNA expression in human THP1 monocytes and human adipose tissue and for comparison in human liver. While fetuin-A was expressed in liver tissue from human donors, it was not expressed in THP1 monocytes or adipose tissue (<a href="#pone.0001765.s001">Figure S1</a>). Furthermore, fetuin-A expression was not detected in adipose tissue from obese and insulin resistant Pima Indians (personal communication Dr. Paska Permana) suggesting that these conditions do not induce fetuin-A expression in adipose tissue in humans. Thus, these data strongly support that the endocrine action of fetuin-A mediates the aforementioned effects.</p>
<div class="figure" id="pone-0001765-g003"><div class="img"><a name="pone-0001765-g003" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001765.g003&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001765" data-uri="info:doi/10.1371/journal.pone.0001765.g003"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001765.g003&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001765.g003/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001765.g003/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001765.g003/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001765.g003/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001765.g003.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001765.g003/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001765.g003/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001765.g003.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 3.  <span>Adiponectin mRNA expression in cultured human adipocytes.</span></strong></p><a id="article1.body1.sec3.sec3.fig1.caption1.p1" name="article1.body1.sec3.sec3.fig1.caption1.p1"></a><p><em>ADIPOQ</em> mRNA expression of human <em>in vitro</em> differentiated adipocytes after treatment with bovine (A) and human (B) fetuin-A for 24 h. Cellular mRNA contents were corrected for 28S-rRNA. Data from adipocyte cultures of four donors are presented. Data were analyzed by Student's t-test.</p>
<span>doi:10.1371/journal.pone.0001765.g003</span></div>

<h4>Relationship of plasma fetuin-A with circulating markers of inflammation and plasma adiponectin</h4>
<a id="article1.body1.sec3.sec4.p1" name="article1.body1.sec3.sec4.p1"></a><p>To investigate whether plasma fetuin-A is associated with circulating markers of inflammation and circulating adiponectin in humans <em>in vivo</em>, we analyzed cross-sectional data from 122 subjects including 80 subjects with normal glucose tolerance, 40 subjects with impaired glucose tolerance, and two patients with newly diagnosed and untreated type 2 diabetes. The subjects covered a wide range of age, body fat content, waist circumference, and circulating fetuin-A (<a href="#pone-0001765-t002">Table 2</a>). Plasma fetuin-A was not associated with circulating IL-6 and TNF-α (both p ≥ 0.82). This finding was not unexpected since both cytokines act in a paracrine, rather than in a systemic fashion <a href="#pone.0001765-Kershaw1">[30]</a>. However, a positive correlation between circulating fetuin-A and hsCRP, a systemic marker of subclinical inflammation, was detected (r = 0.26, p = 0.01, n = 94 with hsCRP above the detection limit of the ELISA). Furthermore, circulating fetuin-A and adiponectin were negatively correlated with each other (r = −0.28, p = 0.02).</p>
<div class="figure" id="pone-0001765-t002"><div class="img"><a name="pone-0001765-t002" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001765.t002&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001765" data-uri="info:doi/10.1371/journal.pone.0001765.t002"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001765.t002&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001765.t002/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001765.t002/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001765.t002/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001765.t002/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001765.t002.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001765.t002/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001765.t002/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001765.t002.TIF"></span>)
                </a></li></ul></div><p><strong>Table 2.  <span>Demographics and metabolic characteristics of the subjects</span></strong></p><span>doi:10.1371/journal.pone.0001765.t002</span></div><a id="article1.body1.sec3.sec4.p2" name="article1.body1.sec3.sec4.p2"></a><p>Next, we assessed the role of plasma fetuin-A as a determinant of circulating adiponectin and its independence of other known determinants of circulating adiponectin by multivariate linear regression analysis (<a href="#pone-0001765-t003">Table 3</a>). Circulating adiponectin was chosen as the dependent variable, and gender, age, body fat, and waist circumference were used as covariates and added step by step (<a href="#pone-0001765-t003">Table 3</a>, models 1–4). This procedure gradually increased the r<sup>2</sup> of the model to 0.39 (<a href="#pone-0001765-t003">Table 3</a>, model 4). Inclusion of plasma fetuin-A as an additional covariate further increased the r<sup>2</sup> to 0.42, and plasma fetuin-A concentration turned out to be an independent determinant of circulating adiponectin (<a href="#pone-0001765-t003">Table 3</a>, model 5).</p>
<div class="figure" id="pone-0001765-t003"><div class="img"><a name="pone-0001765-t003" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001765.t003&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001765" data-uri="info:doi/10.1371/journal.pone.0001765.t003"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001765.t003&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001765.t003/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001765.t003/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001765.t003/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001765.t003/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001765.t003.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001765.t003/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001765.t003/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001765.t003.TIF"></span>)
                </a></li></ul></div><p><strong>Table 3.  <span>Determinants of circulating adiponectin in humans in multivariate linear regression models</span></strong></p><span>doi:10.1371/journal.pone.0001765.t003</span></div>

<h4>Relationship between fetuin-A and multimeric forms of adiponectin</h4>
<a id="article1.body1.sec3.sec5.p1" name="article1.body1.sec3.sec5.p1"></a><p>Plasma adiponectin circulates in several multimeric forms, i.e. trimeric low molecular weight (LMW), hexameric middle molecular weight (MMW) as well as more complex high molecular weight (HMW) structures <a href="#pone.0001765-Tsao1">[31]</a>. We assessed whether fetuin-A affects the formation of a certain form in a subgroup of 49 subjects who underwent the clamp and had plasma samples stored at −80°C (21 men, 28 women; 23–64 years; 16.0–50.0% body fat; 68–119 cm waist circumference). In this subgroup, total plasma adiponectin was positively correlated with hyperinsulinemic euglycemic clamp-derived insulin sensitivity adjusted for gender, age, and body fat (r = 0.40, p = 0.005). Furthermore, plasma fetuin-A tended to negatively correlate with the adjusted insulin sensitivity (r = −0.25, p = 0.08) reflecting our recent data <a href="#pone.0001765-Stefan2">[24]</a>. Plasma fetuin-A correlated negatively with total adiponectin (<a href="#pone-0001765-g004">Figure 4A</a>) and, in particular, with HMW (<a href="#pone-0001765-g004">Figure 4B</a>) and MMW (<a href="#pone-0001765-g004">Figure 4C</a>) adiponectin, but not with LMW adiponectin (<a href="#pone-0001765-g004">Figure 4D</a>).</p>
<div class="figure" id="pone-0001765-g004"><div class="img"><a name="pone-0001765-g004" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001765.g004&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001765" data-uri="info:doi/10.1371/journal.pone.0001765.g004"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001765.g004&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001765.g004/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001765.g004/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001765.g004/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001765.g004/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001765.g004.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001765.g004/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001765.g004/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001765.g004.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 4.  <span>Relationships between circulating fetuin-A and circulating adiponectin in humans.</span></strong></p><a id="article1.body1.sec3.sec5.fig1.caption1.p1" name="article1.body1.sec3.sec5.fig1.caption1.p1"></a><p>Relationship between plasma levels of fetuin-A with total adiponectin and adiponectin's multimeric forms (A–D) in 49 healthy human subjects after adjustment of log-transformed data for age, sex, and percentage of body fat by multivariate linear regression analysis. The regression coefficients as well as the p-value are indicated (HMW–high molecular weight; LMW–low molecular weight; MMW–middle molecular weight).</p>
<span>doi:10.1371/journal.pone.0001765.g004</span></div>
</div>

<div id="section4" class="section"><a id="s4" name="s4" toc="s4" title="Discussion"></a><h3>Discussion</h3><a id="article1.body1.sec4.p1" name="article1.body1.sec4.p1"></a><p>Fetuin-A is a major plasma glycoprotein which was discovered in 1944 <a href="#pone.0001765-Pedersen1">[32]</a>. For a long time, its biological function remained obscure. Using targeted gene disruption, fetuin-A was recently reported to inhibit ectopic calcification <a href="#pone.0001765-JahnenDechent1">[33]</a>, <a href="#pone.0001765-Schafer1">[34]</a>. In keeping with this, fetuin-A deficiency in humans was found to be associated with vascular calcification and mortality in patients on hemodialysis <a href="#pone.0001765-Ketteler1">[35]</a>. However, fetuin-A might exert more functions: several studies demonstrated that fetuin-A can act as a natural inhibitor of the insulin receptor tyrosine kinase in liver and skeletal muscle <a href="#pone.0001765-Auberger1">[3]</a>–<a href="#pone.0001765-Mathews2">[7]</a>, and fetuin-A knockout mice display improved insulin sensitivity and are resistant to weight gain upon a high-fat diet <a href="#pone.0001765-Mathews3">[8]</a>.</p>
<a id="article1.body1.sec4.p2" name="article1.body1.sec4.p2"></a><p>Besides the effects of fetuin-A on muscle and liver insulin signalling, there is increasing evidence that fetuin-A is important for insulin action in adipose tissue <a href="#pone.0001765-Dahlman1">[10]</a>. Moreover, the variability of plasma adiponectin levels is largely explained by a locus on human chromosome 3q27 harbouring both <em>ADIPOQ</em> and, in direct vicinity, <em>AHSG</em>. It is of note that not all variability in plasma adiponectin is explained by genetic variation of the <em>ADIPOQ</em> gene <a href="#pone.0001765-Pollin1">[23]</a>. This led us to investigate whether fetuin-A regulates adiponectin production and, thus, may explain the recently reported association between fetuin-A and the metabolic syndrome <a href="#pone.0001765-Stefan2">[24]</a>, <a href="#pone.0001765-Mori1">[25]</a>. In addition, the metabolic syndrome and hypoadiponectinemia are strongly associated with low-grade inflammation <a href="#pone.0001765-Trujillo1">[27]</a>. Furthermore, high circulating fetuin-A was found to be associated with carotid arterial stiffness <a href="#pone.0001765-Mori2">[36]</a>, a functional property of atherosclerosis that is accompanied by subclinical inflammation. Therefore, we further tested whether fetuin-A treatment affects expression of inflammatory cytokines, a critical step in the generation of low-grade inflammation.</p>
<a id="article1.body1.sec4.p3" name="article1.body1.sec4.p3"></a><p>With the present report, we provide novel data that highly purified fetuin-A exerts strong pro-inflammatory effects as it provoked cytokine expression in monocytes <em>in vitro</em>. The latter are known to infiltrate hypertrophic adipose tissue and to essentially contribute to adipose tissue inflammation <a href="#pone.0001765-Weisberg1">[37]</a>, <a href="#pone.0001765-Xu1">[38]</a>. In addition, we found that, in animals <em>in vivo,</em> fetuin-A treatment increased adipose tissue RNA expression of <em>Il6</em> and <em>Tnf</em> 174- and 27-fold, respectively.</p>
<a id="article1.body1.sec4.p4" name="article1.body1.sec4.p4"></a><p>Besides the effects of fetuin-A on the expression of these inflammatory cytokines, administration of fetuin-A into mice repressed <em>Adipoq</em> mRNA expression in adipose tissue and decreased circulating adiponectin. <em>Lep</em> and <em>Rbp4</em> mRNA expression were not affected by fetuin-A, and albumin did not impair <em>Adipoq</em> mRNA expression. These findings provide evidence that the effect of fetuin-A on <em>Adipoq</em> expression is not due to a general trophic effect <a href="#pone.0001765-Lyles1">[39]</a>. Furthermore, fetuin-A directly affected adipocyte gene expression and these findings were not restricted to rodents: it repressed <em>ADIPOQ</em> expression of <em>in vitro</em> differentiated human adipocytes.</p>
<a id="article1.body1.sec4.p5" name="article1.body1.sec4.p5"></a><p>Based on these findings <em>in vitro</em> and in animals, we further investigated whether circulating fetuin-A was related to low-grade inflammation and circulating adiponectin in humans. Indeed, plasma fetuin-A levels correlated positively with hsCRP levels, as reported previously by Ix <em>et al</em>. <a href="#pone.0001765-Ix1">[26]</a>.</p>
<a id="article1.body1.sec4.p6" name="article1.body1.sec4.p6"></a><p>These findings are somewhat unexpected because CRP is up-regulated in inflammatory states while acute inflammation down-regulates fetuin-A expression in the liver <a href="#pone.0001765-Ruminy1">[40]</a>. Whether, the latter effect is transient and/or reflects compensational mechanisms, needs to be determined. Furthermore, plasma fetuin-A levels correlated negatively with plasma adiponectin levels. In addition, besides other determinants of adiponectin levels, plasma fetuin-A levels were identified as a contributor to the variability in circulating adiponectin. Of note, the observed relationships of fetuin-A with adiponectin in humans were not very strong, nevertheless, they remained statistically significant after adjustment for established determinants of plasma adiponectin levels. This finding supports the assumption of Ix <em>et al.</em> <a href="#pone.0001765-Ix1">[26]</a> that the strong relationship between plasma fetuin-A levels and the metabolic syndrome may be a result of fetuin-A-induced suppression of adiponectin production.</p>
<a id="article1.body1.sec4.p7" name="article1.body1.sec4.p7"></a><p>In addition, fetuin-A was specifically associated with HMW and MMW forms of adiponectin, but not with the LMW form. HMW adiponectin is reported to be the most active adiponectin form <a href="#pone.0001765-Hara1">[41]</a> and represents, among all multimeric forms of adiponectin, the major determinant of insulin resistance, an atherogenic lipoprotein profile, and the metabolic syndrome <a href="#pone.0001765-Hara1">[41]</a>–<a href="#pone.0001765-LaraCastro1">[43]</a>. How fetuin-A determines the assembly of trimeric adiponectin into hexameric MMW and higher-order HMW structures, a process that is supposed to occur during the entry of adiponectin into the bloodstream <a href="#pone.0001765-Tsao1">[31]</a>, is currently unknown and needs further investigation.</p>
<a id="article1.body1.sec4.p8" name="article1.body1.sec4.p8"></a><p>So far, no information is available on fetuin-A-specific cell surface receptors and intracellular signaling pathways making it difficult to assess the molecular mechanisms underlying fetuin-A-induced repression of <em>ADIPOQ</em> expression in adipocytes as well as fetuin-A-mediated induction of cytokine expression in monocytes and adipocytes. Since the <em>ADIPOQ</em> gene is under the control of the transcription factor peroxisome proliferator-activated receptor (PPAR) γ, we also assessed whether PPARγ expression was altered by fetuin-A treatment. Whereas fetuin-A reduced adipose tissue PPARγ expression in mice in vivo, PPARγ expression of adipocytes was not affected (data not shown). The down-regulation of adiponectin and possibly PPARγ expression, appears contradicting to the reported pro-adipogenic effect of fetuin-A <a href="#pone.0001765-Schmidt1">[11]</a>. However, this observation may be due to differential effects of fetuin-A on mature adipocytes and pre-adipocytes, respectively.</p>
<a id="article1.body1.sec4.p9" name="article1.body1.sec4.p9"></a><p>Since we observed a strong effect of fetuin-A on cytokine expression, and IL-6 and TNF-α are well-described negative regulators of adiponectin expression and production <a href="#pone.0001765-Fasshauer1">[44]</a>–<a href="#pone.0001765-Sopasakis1">[49]</a>, we suppose that fetuin-A-induced impairment of adiponectin synthesis may be at least partially mediated by effects of fetuin-A on IL-6 and TNF-α production. Whether this is an exclusive mechanism, or whether fetuin-A regulates adiponectin expression and secretion independently of cytokine production, needs to be determined in future studies.</p>
<a id="article1.body1.sec4.p10" name="article1.body1.sec4.p10"></a><p>Together, the results presented in this work advance our understanding of the role of fetuin-A in the pathophysiology of insulin resistance, atherosclerosis, and the metabolic syndrome. Hepatic steatosis that is strongly related to insulin resistance and type 2 diabetes <a href="#pone.0001765-Roden1">[50]</a>, associates with enhanced hepatic fetuin-A production in rats <a href="#pone.0001765-Lin1">[51]</a> and humans <a href="#pone.0001765-Stefan2">[24]</a>. Elevated circulating levels of fetuin-A negatively affect whole-body insulin sensitivity (i) by impairment of insulin signaling in muscle and liver <a href="#pone.0001765-Auberger1">[3]</a>–<a href="#pone.0001765-Mathews2">[7]</a> and (ii) by triggering inflammation in adipose tissue and suppression of adiponectin production. Generation of an atherogenic lipoprotein profile <a href="#pone.0001765-Chan1">[52]</a>, induction of inflammatory cytokines as well as suppression of the atheroprotective hormone adiponectin <a href="#pone.0001765-Lam1">[53]</a>, therefore, represent plausible molecular pathways linking fatty liver and atherosclerosis <a href="#pone.0001765-Santoliquido1">[54]</a>. In addition, based on the findings from fetuin-A deficient mice that remain lean and insulin sensitive fed a high-fat diet <a href="#pone.0001765-Mathews3">[8]</a>, fetuin-A may have long-term effects on energy expenditure and lipid oxidation, independent of the aforementioned mechanisms.</p>
<a id="article1.body1.sec4.p11" name="article1.body1.sec4.p11"></a><p>In conclusion, we found that fetuin-A induces low-grade inflammation and represses adiponectin production in animals and in humans. These data provide novel evidence on the role of fatty liver in the pathophysiology of insulin resistance and atherosclerosis.</p>
</div>

<div id="section5" class="section"><a id="s5" name="s5" toc="s5" title="Supporting Information"></a><h3>Supporting Information</h3><div class="figshare_widget" doi="10.1371/journal.pone.0001765"></div><a name="pone.0001765.s001" id="pone.0001765.s001"></a><p class="siTitle"><strong><a href="/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0001765.s001">Figure S1. </a></strong></p><p class="siDoi">doi:10.1371/journal.pone.0001765.s001</p><a id="article1.body1.sec5.supplementary-material1.caption1.p1" name="article1.body1.sec5.supplementary-material1.caption1.p1"></a><p class="postSiDOI">(0.50 MB TIF)</p>
</div>





<div><a id="ack" name="ack" toc="ack" title="Acknowledgments"></a><h3>Acknowledgments</h3>
<a id="article1.back1.ack1.p1" name="article1.back1.ack1.p1"></a><p>The authors thank all study participants for their cooperation. We gratefully acknowledge the excellent technical assistance of Anna Bury and Heike Luz who were involved in the clinical tests and Melanie Weisser and Alke Guirguis who were involved in the analytical procedures.</p>
</div><div class="contributions"><a id="authcontrib" name="authcontrib" toc="authcontrib" title="Author Contributions"></a><h3>Author Contributions</h3><p>Conceived and designed the experiments: HH HS FM NS AF AH CW. Performed the experiments: HS NS AH. Analyzed the data: HS NS AF AH. Contributed reagents/materials/analysis tools: HS FM NS AH CW. Wrote the paper: HH HS NS AH.</p></div><div><a id="references" name="references" toc="references" title="References"></a><h3>References</h3><ol class="references"><li><span class="label">1.
              </span><a name="pone.0001765-Dziegielewska1" id="pone.0001765-Dziegielewska1"></a>Dziegielewska KM, Brown WM, Casey SJ, Christie DL, Foreman RC, et al.  (1990) The complete cDNA and amino acid sequence of bovine fetuin. Its homology with alpha 2HS glycoprotein and relation to other members of the cystatin superfamily. J Biol Chem  265: 4354–4357.  <ul class="find" data-citedArticleID="1071452"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=The+complete+cDNA+and+amino+acid+sequence+of+bovine+fetuin.+Its+homology+with+alpha+2HS+glycoprotein+and+relation+to+other+members+of+the+cystatin+superfamily.&amp;auth=&amp;atitle=The+complete+cDNA+and+amino+acid+sequence+of+bovine+fetuin.+Its+homology+with+alpha+2HS+glycoprotein+and+relation+to+other+members+of+the+cystatin+superfamily." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+complete+cDNA+and+amino+acid+sequence+of+bovine+fetuin.+Its+homology+with+alpha+2HS+glycoprotein+and+relation+to+other+members+of+the+cystatin+superfamily." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+complete+cDNA+and+amino+acid+sequence+of+bovine+fetuin.+Its+homology+with+alpha+2HS+glycoprotein+and+relation+to+other+members+of+the+cystatin+superfamily.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">2.
              </span><a name="pone.0001765-Denecke1" id="pone.0001765-Denecke1"></a>Denecke B, Graber S, Schafer C, Heiss A, Woltje M, et al.  (2003) Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A. Biochem J  376: 135–145.  <ul class="find" data-citedArticleID="1071450" data-doi="10.1042/bj20030676"><li><a href="http://dx.doi.org/10.1042/bj20030676" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Tissue+distribution+and+activity+testing+suggest+a+similar+but+not+identical+function+of+fetuin-B+and+fetuin-A." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Tissue+distribution+and+activity+testing+suggest+a+similar+but+not+identical+function+of+fetuin-B+and+fetuin-A.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">3.
              </span><a name="pone.0001765-Auberger1" id="pone.0001765-Auberger1"></a>Auberger P, Falquerho L, Contreres JO, Pages G, Le Cam G, et al.  (1989) Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity. Cell  58: 631–640.  <ul class="find" data-citedArticleID="1071440" data-doi="10.1016/0092-8674(89)90098-6"><li><a href="http://dx.doi.org/10.1016/0092-8674(89)90098-6" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Characterization+of+a+natural+inhibitor+of+the+insulin+receptor+tyrosine+kinase%3A+cDNA+cloning%2C+purification%2C+and+anti-mitogenic+activity." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Characterization+of+a+natural+inhibitor+of+the+insulin+receptor+tyrosine+kinase%3A+cDNA+cloning%2C+purification%2C+and+anti-mitogenic+activity.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">4.
              </span><a name="pone.0001765-Rauth1" id="pone.0001765-Rauth1"></a>Rauth G, Poschke O, Fink E, Eulitz M, Tippmer S, et al.  (1992) The nucleotide and partial amino acid sequences of rat fetuin. Identity with the natural tyrosine kinase inhibitor of the rat insulin receptor. Eur J Biochem  204: 523–529.  <ul class="find" data-citedArticleID="1071506" data-doi="10.1111/j.1432-1033.1992.tb16663.x"><li><a href="http://dx.doi.org/10.1111/j.1432-1033.1992.tb16663.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+nucleotide+and+partial+amino+acid+sequences+of+rat+fetuin.+Identity+with+the+natural+tyrosine+kinase+inhibitor+of+the+rat+insulin+receptor." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+nucleotide+and+partial+amino+acid+sequences+of+rat+fetuin.+Identity+with+the+natural+tyrosine+kinase+inhibitor+of+the+rat+insulin+receptor.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">5.
              </span><a name="pone.0001765-Srinivas1" id="pone.0001765-Srinivas1"></a>Srinivas PR, Wagner AS, Reddy LV, Deutsch DD, Leon MA, et al.  (1993) Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level. Mol Endocrinol  7: 1445–1455.  <ul class="find" data-citedArticleID="1071528" data-doi="10.1210/mend.7.11.7906861"><li><a href="http://dx.doi.org/10.1210/mend.7.11.7906861" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Serum+alpha+2-HS-glycoprotein+is+an+inhibitor+of+the+human+insulin+receptor+at+the+tyrosine+kinase+level." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Serum+alpha+2-HS-glycoprotein+is+an+inhibitor+of+the+human+insulin+receptor+at+the+tyrosine+kinase+level.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">6.
              </span><a name="pone.0001765-Mathews1" id="pone.0001765-Mathews1"></a>Mathews ST, Srinivas PR, Leon MA, Grunberger G (1997) Bovine fetuin is an inhibitor of insulin receptor tyrosine kinase. Life Sci  61: 1583–1592.  <ul class="find" data-citedArticleID="1071488" data-doi="10.1016/s0024-3205(97)00737-6"><li><a href="http://dx.doi.org/10.1016/s0024-3205(97)00737-6" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Bovine+fetuin+is+an+inhibitor+of+insulin+receptor+tyrosine+kinase." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Bovine+fetuin+is+an+inhibitor+of+insulin+receptor+tyrosine+kinase.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">7.
              </span><a name="pone.0001765-Mathews2" id="pone.0001765-Mathews2"></a>Mathews ST, Chellam N, Srinivas PR, Cintron VJ, Leon MA, et al.  (2000) Alpha2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor. Mol Cell Endocrinol  164: 87–98.  <ul class="find" data-citedArticleID="1071490" data-doi="10.1016/s0303-7207(00)00237-9"><li><a href="http://dx.doi.org/10.1016/s0303-7207(00)00237-9" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Alpha2-HSG%2C+a+specific+inhibitor+of+insulin+receptor+autophosphorylation%2C+interacts+with+the+insulin+receptor." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Alpha2-HSG%2C+a+specific+inhibitor+of+insulin+receptor+autophosphorylation%2C+interacts+with+the+insulin+receptor.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">8.
              </span><a name="pone.0001765-Mathews3" id="pone.0001765-Mathews3"></a>Mathews ST, Singh GP, Ranalletta M, Cintron VJ, Qiang X, et al.  (2002) Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes  51: 2450–2458.  <ul class="find" data-citedArticleID="1071492" data-doi="10.2337/diabetes.51.8.2450"><li><a href="http://dx.doi.org/10.2337/diabetes.51.8.2450" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Improved+insulin+sensitivity+and+resistance+to+weight+gain+in+mice+null+for+the+Ahsg+gene." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Improved+insulin+sensitivity+and+resistance+to+weight+gain+in+mice+null+for+the+Ahsg+gene.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">9.
              </span><a name="pone.0001765-Siddiq1" id="pone.0001765-Siddiq1"></a>Siddiq A, Lepretre F, Hercberg S, Froguel P, Gibson F (2005) A synonymous coding polymorphism in the alpha2-Heremans-schmid glycoprotein gene is associated with type 2 diabetes in French Caucasians. Diabetes  54: 2477–2481.  <ul class="find" data-citedArticleID="1071524" data-doi="10.2337/diabetes.54.8.2477"><li><a href="http://dx.doi.org/10.2337/diabetes.54.8.2477" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+synonymous+coding+polymorphism+in+the+alpha2-Heremans-schmid+glycoprotein+gene+is+associated+with+type+2+diabetes+in+French+Caucasians." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+synonymous+coding+polymorphism+in+the+alpha2-Heremans-schmid+glycoprotein+gene+is+associated+with+type+2+diabetes+in+French+Caucasians.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">10.
              </span><a name="pone.0001765-Dahlman1" id="pone.0001765-Dahlman1"></a>Dahlman I, Eriksson P, Kaaman M, Jiao H, Lindgren CM, et al.  (2004) alpha2-Heremans-Schmid glycoprotein gene polymorphisms are associated with adipocyte insulin action. Diabetologia  47: 1974–1979.  <ul class="find" data-citedArticleID="1071448" data-doi="10.1007/s00125-004-1556-7"><li><a href="http://dx.doi.org/10.1007/s00125-004-1556-7" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=alpha2-Heremans-Schmid+glycoprotein+gene+polymorphisms+are+associated+with+adipocyte+insulin+action." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22alpha2-Heremans-Schmid+glycoprotein+gene+polymorphisms+are+associated+with+adipocyte+insulin+action.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">11.
              </span><a name="pone.0001765-Schmidt1" id="pone.0001765-Schmidt1"></a>Schmidt W, Pöll-Jordan G, Löffler G (1990) Adipose conversion of 3T3-L1 cells in a serum-free culture system depends on epidermal growth factor, insulin-like growth factor I, corticosterone, and cyclic AMP. J Biol Chem.  15;265: 15489–15495.  <ul class="find" data-citedArticleID="1071520"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Adipose+conversion+of+3T3-L1+cells+in+a+serum-free+culture+system+depends+on+epidermal+growth+factor%2C+insulin-like+growth+factor+I%2C+corticosterone%2C+and+cyclic+AMP.&amp;auth=&amp;atitle=Adipose+conversion+of+3T3-L1+cells+in+a+serum-free+culture+system+depends+on+epidermal+growth+factor%2C+insulin-like+growth+factor+I%2C+corticosterone%2C+and+cyclic+AMP." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Adipose+conversion+of+3T3-L1+cells+in+a+serum-free+culture+system+depends+on+epidermal+growth+factor%2C+insulin-like+growth+factor+I%2C+corticosterone%2C+and+cyclic+AMP." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Adipose+conversion+of+3T3-L1+cells+in+a+serum-free+culture+system+depends+on+epidermal+growth+factor%2C+insulin-like+growth+factor+I%2C+corticosterone%2C+and+cyclic+AMP.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">12.
              </span><a name="pone.0001765-Kadowaki1" id="pone.0001765-Kadowaki1"></a>Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, et al.  (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest  116: 1784–92.  <ul class="find" data-citedArticleID="1071468" data-doi="10.1172/jci29126"><li><a href="http://dx.doi.org/10.1172/jci29126" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Adiponectin+and+adiponectin+receptors+in+insulin+resistance%2C+diabetes%2C+and+the+metabolic+syndrome." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Adiponectin+and+adiponectin+receptors+in+insulin+resistance%2C+diabetes%2C+and+the+metabolic+syndrome.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">13.
              </span><a name="pone.0001765-Weyer1" id="pone.0001765-Weyer1"></a>Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, et al.  (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab  86: 1930–1935.  <ul class="find" data-citedArticleID="1071544" data-doi="10.1210/jcem.86.5.7463"><li><a href="http://dx.doi.org/10.1210/jcem.86.5.7463" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Hypoadiponectinemia+in+obesity+and+type+2+diabetes%3A+close+association+with+insulin+resistance+and+hyperinsulinemia." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Hypoadiponectinemia+in+obesity+and+type+2+diabetes%3A+close+association+with+insulin+resistance+and+hyperinsulinemia.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">14.
              </span><a name="pone.0001765-Stefan1" id="pone.0001765-Stefan1"></a>Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, et al.  (2002) Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes  51: 1884–1888.  <ul class="find" data-citedArticleID="1071530" data-doi="10.2337/diabetes.51.6.1884"><li><a href="http://dx.doi.org/10.2337/diabetes.51.6.1884" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Plasma+adiponectin+concentration+is+associated+with+skeletal+muscle+insulin+receptor+tyrosine+phosphorylation%2C+and+low+plasma+concentration+precedes+a+decrease+in+whole-body+insulin+sensitivity+in+humans." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Plasma+adiponectin+concentration+is+associated+with+skeletal+muscle+insulin+receptor+tyrosine+phosphorylation%2C+and+low+plasma+concentration+precedes+a+decrease+in+whole-body+insulin+sensitivity+in+humans.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">15.
              </span><a name="pone.0001765-Tschritter1" id="pone.0001765-Tschritter1"></a>Tschritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, et al.  (2003) Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes  52: 239–243.  <ul class="find" data-citedArticleID="1071538" data-doi="10.2337/diabetes.52.2.239"><li><a href="http://dx.doi.org/10.2337/diabetes.52.2.239" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Plasma+adiponectin+concentrations+predict+insulin+sensitivity+of+both+glucose+and+lipid+metabolism." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Plasma+adiponectin+concentrations+predict+insulin+sensitivity+of+both+glucose+and+lipid+metabolism.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">16.
              </span><a name="pone.0001765-Bacha1" id="pone.0001765-Bacha1"></a>Bacha F, Saad R, Gungor N, Arslanian SA (2000) Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function. Diabetes Care  27: 547–552.  <ul class="find" data-citedArticleID="1071442" data-doi="10.2337/diacare.27.2.547"><li><a href="http://dx.doi.org/10.2337/diacare.27.2.547" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Adiponectin+in+youth%3A+relationship+to+visceral+adiposity%2C+insulin+sensitivity%2C+and+beta-cell+function." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Adiponectin+in+youth%3A+relationship+to+visceral+adiposity%2C+insulin+sensitivity%2C+and+beta-cell+function.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">17.
              </span><a name="pone.0001765-Pischon1" id="pone.0001765-Pischon1"></a>Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, et al.  (2004) Plasma adiponectin levels and risk of myocardial infarction in men. JAMA  291: 1730–1737.  <ul class="find" data-citedArticleID="1071502" data-doi="10.1016/j.accreview.2004.06.063"><li><a href="http://dx.doi.org/10.1016/j.accreview.2004.06.063" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Plasma+adiponectin+levels+and+risk+of+myocardial+infarction+in+men." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Plasma+adiponectin+levels+and+risk+of+myocardial+infarction+in+men.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">18.
              </span><a name="pone.0001765-Iglseder1" id="pone.0001765-Iglseder1"></a>Iglseder B, Mackevics V, Stadlmayer A, Tasch G, Ladurner G, et al.  (2005) Plasma adiponectin levels and sonographic phenotypes of subclinical carotid artery atherosclerosis: data from the SAPHIR Study. Stroke  36: 2577–2582.  <ul class="find" data-citedArticleID="1071462" data-doi="10.1161/01.str.0000190834.00284.fd"><li><a href="http://dx.doi.org/10.1161/01.str.0000190834.00284.fd" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Plasma+adiponectin+levels+and+sonographic+phenotypes+of+subclinical+carotid+artery+atherosclerosis%3A+data+from+the+SAPHIR+Study." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Plasma+adiponectin+levels+and+sonographic+phenotypes+of+subclinical+carotid+artery+atherosclerosis%3A+data+from+the+SAPHIR+Study.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">19.
              </span><a name="pone.0001765-Schulze1" id="pone.0001765-Schulze1"></a>Schulze MB, Shai I, Rimm EB, Li T, Rifai M, et al.  (2005) Adiponectin and future coronary heart disease events among men with type 2 diabetes. Diabetes  54: 534–539.  <ul class="find" data-citedArticleID="1071522" data-doi="10.2337/diabetes.54.2.534"><li><a href="http://dx.doi.org/10.2337/diabetes.54.2.534" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Adiponectin+and+future+coronary+heart+disease+events+among+men+with+type+2+diabetes." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Adiponectin+and+future+coronary+heart+disease+events+among+men+with+type+2+diabetes.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">20.
              </span><a name="pone.0001765-Rothenbacher1" id="pone.0001765-Rothenbacher1"></a>Rothenbacher D, Brenner H, Marz W, Koenig W (2005) Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. Eur Heart J  26: 1640–1646.  <ul class="find" data-citedArticleID="1071510" data-doi="10.1093/eurheartj/ehi340"><li><a href="http://dx.doi.org/10.1093/eurheartj/ehi340" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Adiponectin%2C+risk+of+coronary+heart+disease+and+correlations+with+cardiovascular+risk+markers." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Adiponectin%2C+risk+of+coronary+heart+disease+and+correlations+with+cardiovascular+risk+markers.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">21.
              </span><a name="pone.0001765-Vionnet1" id="pone.0001765-Vionnet1"></a>Vionnet N, Hani El-H, Dupont S, Gallina S, Francke S, et al.  (200) Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet  67: 1470–1480.  <ul class="find" data-citedArticleID="1071540" data-doi="10.1086/316887"><li><a href="http://dx.doi.org/10.1086/316887" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Genomewide+search+for+type+2+diabetes-susceptibility+genes+in+French+whites%3A+evidence+for+a+novel+susceptibility+locus+for+early-onset+diabetes+on+chromosome+3q27-qter+and+independent+replication+of+a+type+2-diabetes+locus+on+chromosome+1q21-q24." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Genomewide+search+for+type+2+diabetes-susceptibility+genes+in+French+whites%3A+evidence+for+a+novel+susceptibility+locus+for+early-onset+diabetes+on+chromosome+3q27-qter+and+independent+replication+of+a+type+2-diabetes+locus+on+chromosome+1q21-q24.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">22.
              </span><a name="pone.0001765-Kissebah1" id="pone.0001765-Kissebah1"></a>Kissebah AH, Sonnenberg GE, Myklebust J, Goldstein M, Broman K, et al.  (2000) Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci U S A  97: 14478–14483.  <ul class="find" data-citedArticleID="1071476" data-doi="10.1073/pnas.97.26.14478"><li><a href="http://dx.doi.org/10.1073/pnas.97.26.14478" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Quantitative+trait+loci+on+chromosomes+3+and+17+influence+phenotypes+of+the+metabolic+syndrome." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Quantitative+trait+loci+on+chromosomes+3+and+17+influence+phenotypes+of+the+metabolic+syndrome.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">23.
              </span><a name="pone.0001765-Pollin1" id="pone.0001765-Pollin1"></a>Pollin TI, Tanner K, O'connell JR, Ott SH, Damcott CM, et al.  (2005) Linkage of plasma adiponectin levels to 3q27 explained by association with variation in the APM1 gene. Diabetes  54: 268–274.  <ul class="find" data-citedArticleID="1071504" data-doi="10.2337/diabetes.54.1.268"><li><a href="http://dx.doi.org/10.2337/diabetes.54.1.268" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Linkage+of+plasma+adiponectin+levels+to+3q27+explained+by+association+with+variation+in+the+APM1+gene." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Linkage+of+plasma+adiponectin+levels+to+3q27+explained+by+association+with+variation+in+the+APM1+gene.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">24.
              </span><a name="pone.0001765-Stefan2" id="pone.0001765-Stefan2"></a>Stefan N, Hennige AM, Staiger H, Machann J, Schick F, et al.  (2006) Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care  29: 853–857.  <ul class="find" data-citedArticleID="1071532" data-doi="10.2337/diacare.29.04.06.dc05-1938"><li><a href="http://dx.doi.org/10.2337/diacare.29.04.06.dc05-1938" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Alpha2-Heremans-Schmid+glycoprotein%2Ffetuin-A+is+associated+with+insulin+resistance+and+fat+accumulation+in+the+liver+in+humans." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Alpha2-Heremans-Schmid+glycoprotein%2Ffetuin-A+is+associated+with+insulin+resistance+and+fat+accumulation+in+the+liver+in+humans.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">25.
              </span><a name="pone.0001765-Mori1" id="pone.0001765-Mori1"></a>Mori K, Emoto M, Yokoyama H, Araki T, Teramura M, et al.  (2006) Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects. Diabetes Care  29: 468.  <ul class="find" data-citedArticleID="1071496" data-doi="10.2337/diacare.29.02.06.dc05-1484"><li><a href="http://dx.doi.org/10.2337/diacare.29.02.06.dc05-1484" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Association+of+serum+fetuin-A+with+insulin+resistance+in+type+2+diabetic+and+nondiabetic+subjects." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Association+of+serum+fetuin-A+with+insulin+resistance+in+type+2+diabetic+and+nondiabetic+subjects.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">26.
              </span><a name="pone.0001765-Ix1" id="pone.0001765-Ix1"></a>Ix JH, Shlipak MG, Brandenburg VM, Ali S, Ketteler M, et al.  (2006) Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation  113: 1760–1767.  <ul class="find" data-citedArticleID="1071464" data-doi="10.1161/circulationaha.105.588723"><li><a href="http://dx.doi.org/10.1161/circulationaha.105.588723" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Association+between+human+fetuin-A+and+the+metabolic+syndrome%3A+data+from+the+Heart+and+Soul+Study." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Association+between+human+fetuin-A+and+the+metabolic+syndrome%3A+data+from+the+Heart+and+Soul+Study.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">27.
              </span><a name="pone.0001765-Trujillo1" id="pone.0001765-Trujillo1"></a>Trujillo ME, Scherer PE (2006) Adipose tissue-derived factors: impact on health and disease. Endocr Rev. 2006  27: 762–78.  <ul class="find" data-citedArticleID="1071534" data-doi="10.1210/er.2006-0033"><li><a href="http://dx.doi.org/10.1210/er.2006-0033" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Adipose+tissue-derived+factors%3A+impact+on+health+and+disease." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Adipose+tissue-derived+factors%3A+impact+on+health+and+disease.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">28.
              </span><a name="pone.0001765-Schling1" id="pone.0001765-Schling1"></a>Schling P, Mallow H, Trindl A, Loffler G (1999) Evidence for a local renin angiotensin system in primary cultured human preadipocytes. Int J Obes Relat Metab Disord  23: 336–341.  <ul class="find" data-citedArticleID="1071518" data-doi="10.1038/sj.ijo.0800821"><li><a href="http://dx.doi.org/10.1038/sj.ijo.0800821" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Evidence+for+a+local+renin+angiotensin+system+in+primary+cultured+human+preadipocytes." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Evidence+for+a+local+renin+angiotensin+system+in+primary+cultured+human+preadipocytes.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">29.
              </span><a name="pone.0001765-Matthews1" id="pone.0001765-Matthews1"></a>Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia  28: 412–419.  <ul class="find" data-citedArticleID="1071494" data-doi="10.1007/bf00280883"><li><a href="http://dx.doi.org/10.1007/bf00280883" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Homeostasis+model+assessment%3A+insulin+resistance+and+beta-cell+function+from+fasting+plasma+glucose+and+insulin+concentrations+in+man." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Homeostasis+model+assessment%3A+insulin+resistance+and+beta-cell+function+from+fasting+plasma+glucose+and+insulin+concentrations+in+man.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">30.
              </span><a name="pone.0001765-Kershaw1" id="pone.0001765-Kershaw1"></a>Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab  89: 2548–2556.  <ul class="find" data-citedArticleID="1071472" data-doi="10.1210/jc.2004-0395"><li><a href="http://dx.doi.org/10.1210/jc.2004-0395" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Adipose+tissue+as+an+endocrine+organ." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Adipose+tissue+as+an+endocrine+organ.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">31.
              </span><a name="pone.0001765-Tsao1" id="pone.0001765-Tsao1"></a>Tsao TS, Murrey HE, Hug C, Lee DH, Lodish HF (2002) Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30). J Biol Chem  277: 29359–29362.  <ul class="find" data-citedArticleID="1071536" data-doi="10.1074/jbc.c200312200"><li><a href="http://dx.doi.org/10.1074/jbc.c200312200" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Oligomerization+state-dependent+activation+of+NF-kappa+B+signaling+pathway+by+adipocyte+complement-related+protein+of+30+kDa+%28Acrp30%29." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Oligomerization+state-dependent+activation+of+NF-kappa+B+signaling+pathway+by+adipocyte+complement-related+protein+of+30+kDa+%28Acrp30%29.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">32.
              </span><a name="pone.0001765-Pedersen1" id="pone.0001765-Pedersen1"></a>Pedersen KO (1944) Fetuin, a new globulin isolated from serum. Nature  154: 575.  <ul class="find" data-citedArticleID="1071500" data-doi="10.1038/154575a0"><li><a href="http://dx.doi.org/10.1038/154575a0" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Fetuin%2C+a+new+globulin+isolated+from+serum." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Fetuin%2C+a+new+globulin+isolated+from+serum.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">33.
              </span><a name="pone.0001765-JahnenDechent1" id="pone.0001765-JahnenDechent1"></a>Jahnen-Dechent W, Schafer C, Heiss A, Grotzinger J (2001) Systemic inhibition of spontaneous calcification by the serum protein alpha 2-HS glycoprotein/fetuin. Z Kardiol  90: Suppl 347–56.  <ul class="find" data-citedArticleID="1071466" data-doi="10.1007/s003920170042"><li><a href="http://dx.doi.org/10.1007/s003920170042" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Systemic+inhibition+of+spontaneous+calcification+by+the+serum+protein+alpha+2-HS+glycoprotein%2Ffetuin." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Systemic+inhibition+of+spontaneous+calcification+by+the+serum+protein+alpha+2-HS+glycoprotein%2Ffetuin.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">34.
              </span><a name="pone.0001765-Schafer1" id="pone.0001765-Schafer1"></a>Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M (2003) The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest  112: 357–366.  <ul class="find" data-citedArticleID="1071516" data-doi="10.1172/jci17202"><li><a href="http://dx.doi.org/10.1172/jci17202" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+serum+protein+alpha+2-Heremans-Schmid+glycoprotein%2Ffetuin-A+is+a+systemically+acting+inhibitor+of+ectopic+calcification." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+serum+protein+alpha+2-Heremans-Schmid+glycoprotein%2Ffetuin-A+is+a+systemically+acting+inhibitor+of+ectopic+calcification.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">35.
              </span><a name="pone.0001765-Ketteler1" id="pone.0001765-Ketteler1"></a>Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, et al.  (2003) Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet  361: 827–833.  <ul class="find" data-citedArticleID="1071474" data-doi="10.1016/s0140-6736(03)12710-9"><li><a href="http://dx.doi.org/10.1016/s0140-6736(03)12710-9" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Association+of+low+fetuin-A+%28AHSG%29+concentrations+in+serum+with+cardiovascular+mortality+in+patients+on+dialysis%3A+a+cross-sectional+study." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Association+of+low+fetuin-A+%28AHSG%29+concentrations+in+serum+with+cardiovascular+mortality+in+patients+on+dialysis%3A+a+cross-sectional+study.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">36.
              </span><a name="pone.0001765-Mori2" id="pone.0001765-Mori2"></a>Mori K, Emoto M, Araki T, Yokoyama H, Teramura M, et al.  (2007) Association of serum fetuin-A with carotid arterial stiffness. Clin Endocrinol (Oxf)  66: 246–50.  <ul class="find" data-citedArticleID="1071498" data-doi="10.1111/j.1365-2265.2006.02716.x"><li><a href="http://dx.doi.org/10.1111/j.1365-2265.2006.02716.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Association+of+serum+fetuin-A+with+carotid+arterial+stiffness." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Association+of+serum+fetuin-A+with+carotid+arterial+stiffness.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">37.
              </span><a name="pone.0001765-Weisberg1" id="pone.0001765-Weisberg1"></a>Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, et al.  (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest  112: 1796–1808.  <ul class="find" data-citedArticleID="1071542" data-doi="10.1172/jci19246"><li><a href="http://dx.doi.org/10.1172/jci19246" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Obesity+is+associated+with+macrophage+accumulation+in+adipose+tissue." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Obesity+is+associated+with+macrophage+accumulation+in+adipose+tissue.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">38.
              </span><a name="pone.0001765-Xu1" id="pone.0001765-Xu1"></a>Xu H, Barnes GT, Yang Q, Tan G, Yang D, et al.  (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest  112: 1821–1830.  <ul class="find" data-citedArticleID="1071546" data-doi="10.1172/jci19451"><li><a href="http://dx.doi.org/10.1172/jci19451" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Chronic+inflammation+in+fat+plays+a+crucial+role+in+the+development+of+obesity-related+insulin+resistance." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Chronic+inflammation+in+fat+plays+a+crucial+role+in+the+development+of+obesity-related+insulin+resistance.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">39.
              </span><a name="pone.0001765-Lyles1" id="pone.0001765-Lyles1"></a>Lyles JM, Amin W, Bock E, Weill CL (1993) Regulation of NCAM by growth factors in serum-free myotube cultures. J Neurosci Res  34: 273–286.  <ul class="find" data-citedArticleID="1071486" data-doi="10.1002/jnr.490340304"><li><a href="http://dx.doi.org/10.1002/jnr.490340304" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Regulation+of+NCAM+by+growth+factors+in+serum-free+myotube+cultures." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Regulation+of+NCAM+by+growth+factors+in+serum-free+myotube+cultures.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">40.
              </span><a name="pone.0001765-Ruminy1" id="pone.0001765-Ruminy1"></a>Ruminy P, Gangneux C, Claeyssens S, Scotte M, Daveau M, et al.  (2001) Gene transcription in hepatocytes during the acute phase of a systemic inflammation: from transcription factors to target genes. Inflamm Res.  50: 383–390.  <ul class="find" data-citedArticleID="1071512" data-doi="10.1007/pl00000260"><li><a href="http://dx.doi.org/10.1007/pl00000260" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Gene+transcription+in+hepatocytes+during+the+acute+phase+of+a+systemic+inflammation%3A+from+transcription+factors+to+target+genes." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Gene+transcription+in+hepatocytes+during+the+acute+phase+of+a+systemic+inflammation%3A+from+transcription+factors+to+target+genes.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">41.
              </span><a name="pone.0001765-Hara1" id="pone.0001765-Hara1"></a>Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O (2006) Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care  29: 1357–1362.  <ul class="find" data-citedArticleID="1071460" data-doi="10.2337/dc05-1801"><li><a href="http://dx.doi.org/10.2337/dc05-1801" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Measurement+of+the+high-molecular+weight+form+of+adiponectin+in+plasma+is+useful+for+the+prediction+of+insulin+resistance+and+metabolic+syndrome." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Measurement+of+the+high-molecular+weight+form+of+adiponectin+in+plasma+is+useful+for+the+prediction+of+insulin+resistance+and+metabolic+syndrome.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">42.
              </span><a name="pone.0001765-Fisher1" id="pone.0001765-Fisher1"></a>Fisher FF, Trujillo ME, Hanif W, Barnett AH, McTernan PG, et al.  (2005) Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males. Diabetologia  48: 1084–1087.  <ul class="find" data-citedArticleID="1071458" data-doi="10.1007/s00125-005-1758-7"><li><a href="http://dx.doi.org/10.1007/s00125-005-1758-7" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Serum+high+molecular+weight+complex+of+adiponectin+correlates+better+with+glucose+tolerance+than+total+serum+adiponectin+in+Indo-Asian+males." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Serum+high+molecular+weight+complex+of+adiponectin+correlates+better+with+glucose+tolerance+than+total+serum+adiponectin+in+Indo-Asian+males.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">43.
              </span><a name="pone.0001765-LaraCastro1" id="pone.0001765-LaraCastro1"></a>Lara-Castro C, Luo N, Wallace P, Klein RL, Garvey WT (2006) Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes  55: 249–259.  <ul class="find" data-citedArticleID="1071480" data-doi="10.2337/diabetes.55.01.06.db05-1105"><li><a href="http://dx.doi.org/10.2337/diabetes.55.01.06.db05-1105" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Adiponectin+multimeric+complexes+and+the+metabolic+syndrome+trait+cluster." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Adiponectin+multimeric+complexes+and+the+metabolic+syndrome+trait+cluster.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">44.
              </span><a name="pone.0001765-Fasshauer1" id="pone.0001765-Fasshauer1"></a>Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R (2002) Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun  290: 1084–1089.  <ul class="find" data-citedArticleID="1071454" data-doi="10.1006/bbrc.2001.6307"><li><a href="http://dx.doi.org/10.1006/bbrc.2001.6307" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Hormonal+regulation+of+adiponectin+gene+expression+in+3T3-L1+adipocytes." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Hormonal+regulation+of+adiponectin+gene+expression+in+3T3-L1+adipocytes.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">45.
              </span><a name="pone.0001765-Kappes1" id="pone.0001765-Kappes1"></a>Kappes A, Loffler G (2000) Influences of ionomycin, dibutyryl-cycloAMP and tumour necrosis factor-alpha on intracellular amount and secretion of apM1 in differentiating primary human preadipocytes. Horm Metab Res  32: 548–554.  <ul class="find" data-citedArticleID="1071470" data-doi="10.1055/s-2007-978684"><li><a href="http://dx.doi.org/10.1055/s-2007-978684" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Influences+of+ionomycin%2C+dibutyryl-cycloAMP+and+tumour+necrosis+factor-alpha+on+intracellular+amount+and+secretion+of+apM1+in+differentiating+primary+human+preadipocytes." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Influences+of+ionomycin%2C+dibutyryl-cycloAMP+and+tumour+necrosis+factor-alpha+on+intracellular+amount+and+secretion+of+apM1+in+differentiating+primary+human+preadipocytes.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">46.
              </span><a name="pone.0001765-Bruun1" id="pone.0001765-Bruun1"></a>Bruun JM, Lihn AS, Verdich C, Pedersen SB, Toubro S, et al.  (2003) Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab  285: E527–E533.  <ul class="find" data-citedArticleID="1071444"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Regulation+of+adiponectin+by+adipose+tissue-derived+cytokines%3A+in+vivo+and+in+vitro+investigations+in+humans.&amp;auth=&amp;atitle=Regulation+of+adiponectin+by+adipose+tissue-derived+cytokines%3A+in+vivo+and+in+vitro+investigations+in+humans." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Regulation+of+adiponectin+by+adipose+tissue-derived+cytokines%3A+in+vivo+and+in+vitro+investigations+in+humans." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Regulation+of+adiponectin+by+adipose+tissue-derived+cytokines%3A+in+vivo+and+in+vitro+investigations+in+humans.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">47.
              </span><a name="pone.0001765-Lihn1" id="pone.0001765-Lihn1"></a>Lihn AS, Richelsen B, Pedersen SB, Haugaard SB, Rathje GS, et al.  (2003) Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels. Am J Physiol Endocrinol Metab  285: E1072–E1080.  <ul class="find" data-citedArticleID="1071482"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Increased+expression+of+TNF-alpha%2C+IL-6%2C+and+IL-8+in+HALS%3A+implications+for+reduced+adiponectin+expression+and+plasma+levels.&amp;auth=&amp;atitle=Increased+expression+of+TNF-alpha%2C+IL-6%2C+and+IL-8+in+HALS%3A+implications+for+reduced+adiponectin+expression+and+plasma+levels." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Increased+expression+of+TNF-alpha%2C+IL-6%2C+and+IL-8+in+HALS%3A+implications+for+reduced+adiponectin+expression+and+plasma+levels." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Increased+expression+of+TNF-alpha%2C+IL-6%2C+and+IL-8+in+HALS%3A+implications+for+reduced+adiponectin+expression+and+plasma+levels.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">48.
              </span><a name="pone.0001765-Fasshauer2" id="pone.0001765-Fasshauer2"></a>Fasshauer M, Kralisch S, Klier M, Lossner U, Bluher M, et al.  (2003) Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun  301: 1045–1050.  <ul class="find" data-citedArticleID="1071456" data-doi="10.1016/s0006-291x(03)00090-1"><li><a href="http://dx.doi.org/10.1016/s0006-291x(03)00090-1" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Adiponectin+gene+expression+and+secretion+is+inhibited+by+interleukin-6+in+3T3-L1+adipocytes." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Adiponectin+gene+expression+and+secretion+is+inhibited+by+interleukin-6+in+3T3-L1+adipocytes.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">49.
              </span><a name="pone.0001765-Sopasakis1" id="pone.0001765-Sopasakis1"></a>Sopasakis VR, Sandqvist M, Gustafson B, Hammarstedt A, Schmelz M, et al.  (2004) High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator. Obes Res  12: 454–460.  <ul class="find" data-citedArticleID="1071526" data-doi="10.1038/oby.2004.51"><li><a href="http://dx.doi.org/10.1038/oby.2004.51" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=High+local+concentrations+and+effects+on+differentiation+implicate+interleukin-6+as+a+paracrine+regulator." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22High+local+concentrations+and+effects+on+differentiation+implicate+interleukin-6+as+a+paracrine+regulator.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">50.
              </span><a name="pone.0001765-Roden1" id="pone.0001765-Roden1"></a>Roden M (2006) Mechanisms of Disease: hepatic steatosis in type 2 diabetes–pathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab  2: 335–48.  <ul class="find" data-citedArticleID="1071508" data-doi="10.1038/ncpendmet0190"><li><a href="http://dx.doi.org/10.1038/ncpendmet0190" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Mechanisms+of+Disease%3A+hepatic+steatosis+in+type+2+diabetes%E2%80%93pathogenesis+and+clinical+relevance." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Mechanisms+of+Disease%3A+hepatic+steatosis+in+type+2+diabetes%E2%80%93pathogenesis+and+clinical+relevance.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">51.
              </span><a name="pone.0001765-Lin1" id="pone.0001765-Lin1"></a>Lin X, Braymer HD, Bray GA, York DA (1998) Differential expression of insulin receptor tyrosine kinase inhibitor (fetuin) gene in a model of diet-induced obesity. Life Sci  63: 145–153.  <ul class="find" data-citedArticleID="1071484" data-doi="10.1016/s0024-3205(98)00250-1"><li><a href="http://dx.doi.org/10.1016/s0024-3205(98)00250-1" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Differential+expression+of+insulin+receptor+tyrosine+kinase+inhibitor+%28fetuin%29+gene+in+a+model+of+diet-induced+obesity." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Differential+expression+of+insulin+receptor+tyrosine+kinase+inhibitor+%28fetuin%29+gene+in+a+model+of+diet-induced+obesity.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">52.
              </span><a name="pone.0001765-Chan1" id="pone.0001765-Chan1"></a>Chan DC, Barrett HP, Watts GF (2004) Dyslipidemia in visceral obesity: mechanisms, implications, and therapy. Am J Cardiovasc Drugs  4: 227–246.  <ul class="find" data-citedArticleID="1071446" data-doi="10.2165/00129784-200404040-00004"><li><a href="http://dx.doi.org/10.2165/00129784-200404040-00004" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Dyslipidemia+in+visceral+obesity%3A+mechanisms%2C+implications%2C+and+therapy." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Dyslipidemia+in+visceral+obesity%3A+mechanisms%2C+implications%2C+and+therapy.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">53.
              </span><a name="pone.0001765-Lam1" id="pone.0001765-Lam1"></a>Lam KS, Xu A (2005) Adiponectin: protection of the endothelium. Curr Diab Rep  5: 254–259.  <ul class="find" data-citedArticleID="1071478" data-doi="10.1007/s11892-005-0019-y"><li><a href="http://dx.doi.org/10.1007/s11892-005-0019-y" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Adiponectin%3A+protection+of+the+endothelium." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Adiponectin%3A+protection+of+the+endothelium.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">54.
              </span><a name="pone.0001765-Santoliquido1" id="pone.0001765-Santoliquido1"></a>Santoliquido A, Di Campli C, Miele L, Gabrieli ML, Forgione A, et al.  (2005) Hepatic steatosis and vascular disease. Eur Rev Med Pharmacol Sci  9: 269–271.  <ul class="find" data-citedArticleID="1071514"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Hepatic+steatosis+and+vascular+disease.&amp;auth=&amp;atitle=Hepatic+steatosis+and+vascular+disease." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Hepatic+steatosis+and+vascular+disease." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Hepatic+steatosis+and+vascular+disease.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li></ol></div>

  </div>

      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.XML" value="109924"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.PDF" value="319322"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.t001.PNG_L" value="189936"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.t001.PNG_M" value="125202"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.t001.PNG_S" value="13176"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.t001.TIF" value="911690"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.t001.PNG_I" value="39593"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.g001.PNG_L" value="303498"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.g001.PNG_M" value="37201"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.g001.PNG_S" value="7919"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.g001.TIF" value="765690"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.g001.PNG_I" value="12909"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.g002.PNG_L" value="347460"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.g002.PNG_M" value="41944"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.g002.PNG_S" value="8383"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.g002.TIF" value="827106"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.g002.PNG_I" value="14772"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.g003.PNG_L" value="526761"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.g003.PNG_M" value="21658"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.g003.PNG_S" value="6815"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.g003.TIF" value="1735200"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.g003.PNG_I" value="22800"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.t002.PNG_L" value="126857"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.t002.PNG_M" value="152198"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.t002.PNG_S" value="18771"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.t002.TIF" value="629504"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.t002.PNG_I" value="62318"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.t003.PNG_L" value="111845"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.t003.PNG_M" value="121736"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.t003.PNG_S" value="17797"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.t003.TIF" value="613438"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.t003.PNG_I" value="58057"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.g004.PNG_L" value="169350"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.g004.PNG_M" value="50694"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.g004.PNG_S" value="8434"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.g004.TIF" value="630790"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.g004.PNG_I" value="17679"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001765.s001.TIF" value="393613"/>

</div>
<div class="sidebar">

  <div class="article-actions cf">
      <div class="download">
        <span class="btn"><a href="/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0001765&amp;representation=PDF" title="Download" target="_blank">Download PDF</a></span>
      </div>
      <div class="btn-reveal dropdown">
        <div class="dropdown-icon">
          <span class="btn">&nbsp;</span>
        </div>

        <div class="content">
          <ul class="bullet">
            <li><a href="/article/citationList.action?articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001765" title="Download citations">Citation</a></li>
            <li><a href="/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0001765&amp;representation=XML" title="Download article XML">XML</a></li>
          </ul>
        </div>
      </div> <!-- end btn-reveal dropdown-->


    <div class="btn-reveal flt-l">
        <span class="btn">Print</span>
        <div class="content">
            <ul class="bullet">
                <li id="print-article"><a href="#" onclick="if(typeof(_gaq) != 'undefined'){ _gaq.push(['_trackEvent','Article', 'Print', 'Click']); } window.print(); return false;" title="Print Article">Print article</a></li>
                <li>
                  <a href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=7&doi=10.1371/journal.pone.0001765&volume=&issue=&title=Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin Production&author_name=Anita%20M.%20Hennige%2C%20Harald%20Staiger%2C%20Corinna%20Wicke%2C%20Fausto%20Machicao%2C%20Andreas%20Fritsche%2C%20Hans-Ulrich%20H%C3%A4ring%2C%20Norbert%20Stefan&start_page=1&end_page=9" title="Odyssey Press">EzReprint</a>
                </li>
            </ul>
        </div>
    </div>

    <div class="btn-reveal flt-r">
        <span class="btn">Share</span>
        <div class="content">
            <ul class="social">
                <li><a href="http://www.reddit.com/submit?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001765" target="_blank" title="Submit to Reddit"><img src="/images/icon.reddit.16.png" width="16" height="16" alt="Reddit">Reddit</a></li>

                <li><a href="https://plus.google.com/share?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001765" target="_blank" title="Share on Google+"><img src="/images/icon.gplus.16.png" width="16" height="16" alt="Google+">Google+</a></li>

                <li><a href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.plosone.org%2Farticle%2Finfo%253Adoi%252F10.1371%252Fjournal.pone.0001765" target="_blank" title="Add to StumbleUpon"><img src="/images/icon.stumble.16.png" width="16" height="16" alt="StumbleUpon">StumbleUpon</a></li>

                <li><a href="http://www.facebook.com/share.php?u=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001765&amp;t=Fetuin-A%20Induces%20Cytokine%20Expression%20and%20Suppresses%20Adiponectin%20Production" target="_blank" title="Share on Facebook"><img src="/images/icon.fb.16.png" width="16" height="16" alt="Facebook">Facebook</a></li>

                <li><a href="http://www.linkedin.com/shareArticle?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001765&title=Fetuin-A%20Induces%20Cytokine%20Expression%20and%20Suppresses%20Adiponectin%20Production&summary=Checkout%20this%20article%20I%20found%20at%20PLOS" target="_blank" title="Add to LinkedIn"><img src="/images/icon.linkedin.16.png" width="16" height="16" alt="Mendeley">LinkedIn</a></li>

                <li><a href="http://www.citeulike.org/posturl?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001765&amp;title=Fetuin-A%20Induces%20Cytokine%20Expression%20and%20Suppresses%20Adiponectin%20Production" target="_blank" title="Add to CiteULike"><img src="/images/icon.cul.16.png" width="16" height="16" alt="CiteULike">CiteULike</a></li>

                <li><a href="http://www.mendeley.com/import/?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001765" target="_blank" title="Add to Mendeley"><img src="/images/icon.mendeley.16.png" width="16" height="16" alt="Mendeley">Mendeley</a></li>

                <li><a href="https://www.pubchase.com/library?add_aid=10.1371%2Fjournal.pone.0001765&amp;source=plos" target="_blank" title="Add to PubChase"><img src="/images/icon.pc.16.png" width="16" height="16" alt="PubChase">PubChase</a></li>


                <script type="text/javascript">
                    // replace tweet with one that's pre-shortened to 140 chars
                    function truncateTweetText() {
                        var twtTitle = 'Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin Production';
                        var twtUrl = 'http://dx.plos.org/10.1371/journal.pone.0001765';
                        // all URLs posted to twitter get auto-shortened to 20 chars.
                        var maxLength = 140 - (20 + 1);
                        // truncate the title to include space for twtTag and ellipsis (here, 10 = tag length + space + ellipsis)
                        if (twtTitle.length > maxLength) { twtTitle = twtTitle.substr(0, (maxLength - 10)) + '...'; }
                        // set the href to use the shortened tweet
                        $('#twitter-share-link').prop('href', 'http://twitter.com/intent/tweet?text=' + encodeURIComponent('#PLOSONE: ' + twtTitle + ' ' + twtUrl));
                    }
                </script>
                <li><a href="http://twitter.com/intent/tweet?text=#PLOSONE%3A%20Fetuin-A%20Induces%20Cytokine%20Expression%20and%20Suppresses%20Adiponectin%20Production http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001765" onclick="truncateTweetText();" target="_blank" title="Share on Twitter" id="twitter-share-link"><img src="/images/icon.twtr.16.png" width="16" height="16" alt="Twitter">Twitter</a></li>

                <li><a href="/article/email/info%3Adoi%2F10.1371%2Fjournal.pone.0001765" title="Email this article"><img src="/images/icon.email.16.png" width="16" height="16" alt="Email">Email</a></li>
            </ul>
        </div>
    </div><!--end btn-reveal flt-r-->
</div><!-- end article-actions-->

<!-- begin Crossmark -->

<a id="open-crossmark" href="#" style="margin-top: -28px; display:block"><img style="border: 0; display: none;
 padding: 10px 0 18px 0;"  id="crossmark-icon" src="/images/logo-crossmark-bw.png" /></a>
<div id="crossmark-dialog" style="display: none;" title="">
    <!-- the external CrossMark data is loaded inside this iframe -->
    <iframe id="crossmark-dialog-frame" frameborder="0"></iframe>
</div>

<!-- end crossmark -->


<div class="block" id="subject-area-sidebar-block">
    <div class="header">
        <h3>Subject Areas</h3><div title="More information" id="subject-area-sidebar-block-help-icon"><img align="right"
                                                                                                           alt="info" src="/images/button_info.png"/><div id="subject-area-sidebar-block-help"><img align="right"
                                                                                                                                                                                                    src="/images/button_info.png"/><p>
        <b>We want your feedback.</b> Do these subject areas make sense for this article? If not, click the flag
        next to the incorrect subject area and we will review it. Thanks for your help!
    </p></div></div>
    </div>


    <ul id="subject-area-sidebar-list">






















          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Adipocyte+differentiation%22" title="Search for articles in the subject area:'Adipocyte differentiation'"><div class="flagText">Adipocyte differentiation</div></a>
              <div data-categoryid="24451" data-articleid="26354"
                   data-categoryname="Adipocyte differentiation"
                   class="flagImage" title="Flag 'Adipocyte differentiation' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Adipocytes%22" title="Search for articles in the subject area:'Adipocytes'"><div class="flagText">Adipocytes</div></a>
              <div data-categoryid="22369" data-articleid="26354"
                   data-categoryname="Adipocytes"
                   class="flagImage" title="Flag 'Adipocytes' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Adiponectin%22" title="Search for articles in the subject area:'Adiponectin'"><div class="flagText">Adiponectin</div></a>
              <div data-categoryid="25353" data-articleid="26354"
                   data-categoryname="Adiponectin"
                   class="flagImage" title="Flag 'Adiponectin' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Adipose+tissue%22" title="Search for articles in the subject area:'Adipose tissue'"><div class="flagText">Adipose tissue</div></a>
              <div data-categoryid="48059" data-articleid="26354"
                   data-categoryname="Adipose tissue"
                   class="flagImage" title="Flag 'Adipose tissue' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Blood+plasma%22" title="Search for articles in the subject area:'Blood plasma'"><div class="flagText">Blood plasma</div></a>
              <div data-categoryid="32385" data-articleid="26354"
                   data-categoryname="Blood plasma"
                   class="flagImage" title="Flag 'Blood plasma' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Cytokines%22" title="Search for articles in the subject area:'Cytokines'"><div class="flagText">Cytokines</div></a>
              <div data-categoryid="47517" data-articleid="26354"
                   data-categoryname="Cytokines"
                   class="flagImage" title="Flag 'Cytokines' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Inflammation%22" title="Search for articles in the subject area:'Inflammation'"><div class="flagText">Inflammation</div></a>
              <div data-categoryid="32301" data-articleid="26354"
                   data-categoryname="Inflammation"
                   class="flagImage" title="Flag 'Inflammation' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Insulin%22" title="Search for articles in the subject area:'Insulin'"><div class="flagText">Insulin</div></a>
              <div data-categoryid="32279" data-articleid="26354"
                   data-categoryname="Insulin"
                   class="flagImage" title="Flag 'Insulin' as inappropriate"></div>
          </li>
    </ul>
</div>

<div class="ad">
    <div class="title">Advertisement</div>






  <iframe id='a0852f54' name='a0852f54'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=381&amp;cb=7108'
    frameborder='0' scrolling='no' width='160' height='600'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a0852f54&amp;cb=1612'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=381&amp;cb=2195&amp;n=a0852f54'
      border='0' alt=''/>
    </a>
  </iframe>



</div>

<div id="twitter-alm-timeline" class="twitter-alm-timeline"></div>

<div class="block sidebar-comments">
    <div class="header">
        <h3>Comments</h3>
    </div>
      <p><a href="/annotation/listThread.action?root=11437">Referee Comments: Referee 1 (Antonio Vidal-Puig)</a><br>Posted by PLoS_ONE_Group</p>
</div>

</div><!-- sidebar -->
    </div>
  </div>
</div>
<script src="http://wl.figshare.com/static/p_widget.js" type="text/javascript"></script><div id="pageftr">
  <div class="ftr-cols cf">
    <div class="col col-1">
      <img src="/images/logo-plos-footer.png" alt="PLOS Logo" class="logo" />
      <p><a href="/static/releaseNotes">Ambra 2.9.16</a> Managed Colocation provided <br />by <a href="http://www.isc.org/">Internet Systems Consortium</a>.<p>
      <div class="nav nav-aux">
        <a href="/static/privacy">Privacy Policy</a> |
        <a href="/static/terms">Terms of Use</a> |
        <a href="http://www.plos.org/advertise/">Advertise</a> |
        <a href="http://www.plos.org/about/media-inquiries/">Media Inquiries</a>
      </div>
    </div>
    <div class="col col-2">
      <p><a href="http://www.plos.org/publications/journals/">Publications</a></p>
      <div class="nav">
        <ul>
          <li><a href="http://www.plosbiology.org">PLOS Biology</a></li>
          <li><a href="http://www.plosmedicine.org">PLOS Medicine</a></li>
          <li><a href="http://www.ploscompbiol.org">PLOS Computational Biology</a></li>
          <li><a href="http://currents.plos.org">PLOS Currents</a></li>
          <li><a href="http://www.plosgenetics.org">PLOS Genetics</a></li>
          <li><a href="http://www.plospathogens.org">PLOS Pathogens</a></li>
          <li><a href="http://www.plosone.org">PLOS ONE</a></li>
          <li><a href="http://www.plosntds.org">PLOS Neglected Tropical Diseases</a></li>
        </ul>
      </div>
    </div>
    <div class="col col-3">
      <div class="nav">
        <p><a href="http://www.plos.org">plos.org</a></p>
        <p><a href="http://blogs.plos.org">Blogs</a></p>
        <p><a href="http://www.ploscollections.org">Collections</a></p>
        <p><a href="/feedback/new">Send us feedback</a></p>

        <p>California (US) corporation #C2354500, based in San Francisco</p>
      </div>
    </div>
  </div>
</div><!-- pageftr -->

</div><!-- end page-wrap, this div is in header.ftl -->
<script type="text/javascript" src="/javascript/jquery-1.8.1-min.js?v=Tm7VCOzZz3lE03ghpkS6SWkHbyI"></script>
<script type="text/javascript" src="/javascript/ga-min.js?v=lNQ4gt8QcPDatjsdOFl_FGpPhLY"></script>
<script type="text/javascript" src="/javascript/jquery.hoverIntent-min.js?v=mRiGNYY9cIXxVb8u0K_MdW7hHnc"></script>
<script type="text/javascript" src="/javascript/jquery.placeholder-min.js?v=21Pn56Ur9h1N4K4VZDa0nqI3Pxo"></script>
<script type="text/javascript" src="/javascript/jquery.jsonp-2.4.0-min.js?v=lqTpzoHfSq3I5Ygo01qq5WankEo"></script>
<script type="text/javascript" src="/javascript/jquery-ui-1.9.2.custom-min.js?v=raSSlfNO0YsV5uUpAKmTB9n5VTc"></script>
<script type="text/javascript" src="/javascript/jquery.tooltip-min.js?v=cw+6Smh+mdryIA25xvqIvHMrnZM"></script>
<script type="text/javascript" src="/javascript/jquery.uniform-min.js?v=kYUAnX6W2W_2fK3RIuQ2m_YFG9U"></script>
<script type="text/javascript" src="/javascript/jquery.pjax-min.js?v=939kLBjL5_YKbx71T1RHjYaD4l8"></script>
<script type="text/javascript" src="/javascript/imagesloaded-min.js?v=XeuAp8Gc3mvQUo+wZCSF8ttPwvw"></script>
<script type="text/javascript" src="/javascript/figviewer-min.js?v=yPUa0sUQ_iHkI+IRv2i9bjyZJFo"></script>
<script type="text/javascript" src="/javascript/global-min.js?v=0Q3PwjeaWtXYDnqIsQvnL_ou0qs"></script>
<script type="text/javascript" src="/javascript/jquery.touchswipe-min.js?v=huaek_e6HqTduvCNAN91dJolTyw"></script>
<script type="text/javascript" src="/javascript/jquery.base64-min.js?v=VwV1zeVqKZj5FCAdlK0q5NRxbBg"></script>
<script type="text/javascript" src="/javascript/alm-min.js?v=Y5gm6B0b4Kx2YHNObNrgEeBgXlY"></script>
<script type="text/javascript" src="/javascript/taxonomy-browser-min.js?v=vBVMuDMYkGJCXIUxLe35GoyiJNw"></script>
<script type="text/javascript" src="/javascript/jquery.filterize-min.js?v=j0ZKVnHyk2nhFy8eIuNJkp7xaM0"></script>
<script type="text/javascript" src="/javascript/plosone-min.js?v=TK4H4arL_XBSwwJq+K1N3kqYfAI"></script>
<script type="text/javascript" src="/javascript/twitter-min.js?v=xKgcxLsQFXy+at1ao1NVke8nFlM"></script>
<script type="text/javascript" src="/javascript/crossmark.1.4-min.js?v=3FO4k0SjwTaGNnKGNSqthar1080"></script>
<script type="text/javascript">
  var _sf_async_config={uid:16579,domain:"plosone.org"};
  (function(){
    function loadChartbeat() {
      window._sf_endpt=(new Date()).getTime();
      var e = document.createElement('script');
      e.setAttribute('language', 'javascript');
      e.setAttribute('type', 'text/javascript');
      e.setAttribute('src',
          (("https:" == document.location.protocol) ? "https://a248.e.akamai.net/chartbeat.download.akamai.com/102508/" : "http://static.chartbeat.com/") +
              "js/chartbeat.js");
      document.body.appendChild(e);
    }
    var oldonload = window.onload;
    window.onload = (typeof window.onload != 'function') ?
        loadChartbeat : function() { oldonload(); loadChartbeat(); };
  })();
</script>
<!-- <script type="application/javascript" src="http://crossmark.crossref.org/javascripts/v1.3/crossmark.min.js"></script> -->

</body>
</html>
